Full Judgment Text
Text read from the judgment PDF published on the High Court's eCourts portal, through the
Indian High Court Judgments open data set (Dattam Labs,
CC BY 4.0).
The court's own copy is the authoritative text.
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
IN THE HIGH COURT OF SIKKIM : GANGTOK
(CIVIL EXTRA ORDINARY JURISDICTION)
---------------------------------------------------------------------------------------
D.B.: HOB’BLE MR. JUSTICE SATISH K AGNIHOTRI, CJ &
HON’BLE MR. JUSTICE BHASKAR RAJ PRADHAN, J.
--------------------------------------------------------------------------------------
WP(C) No. 41/2015
with
WP (C) No. 8/2017
with
WP (C) No. 27/2017
&
WP(C) No. 40/2017
Sun Pharma Laboratories Limited
Formally known as Sun Pharma Drugs Pvt. Ltd./
Sun Pharma Sikkim
Plot No. 754, Setipool, P.O. Ranipool
East Sikkim, Sikkim 737135
.… Petitioner
Versus
1. The Union of India
through the Secretary,
Ministry of Finannce Department of Revenue,
North Block, New Delhi
2.
The commisioner,
Central Excise Customs and Service Tax,
Siliguri Commissionerate, Central Avenue Building,
4th Floor, Haren Mukherjee Road, Hakimpara, Siliguri.
3. The Deputy Commissioner of Central Excise and Service
Tax, Gangtok Division, Siliguri, C.R Building, Haren
Mukherjee Road, Hakimpara, Siliguri-734001.
4.
Assistant Commissioner,
Central Excise and Service Tax,
Gangtok Division, Siliguri,
C.R Building, Haren Mukherjee Road,
Hakimpara, Siliguri-734001.
.... Respondents
------------------------------------------------------------------------------------Appearance:
Mr. Vikram Nankani, Sr. Advocate with Ms. Sangita Pradhan and
Mr. Nanda Gopal, Advocates for the Petitioner.
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
Mr. Kaushik Chanda, Addl. Solicitor General with Mr. B.K Gupta,
Advocates for the Respondents.
---------------------------------------------------------------------------------
JUDGMENT
(21.11.2017)
Bhaskar Raj Pradhan, J.
1.
A classical dispute between the tax collector and the tax payer
has led to the filing of four Writ Petitions before this Court whereby the
tax payer seeks to invoke against the tax collector, the well settled
doctrine of promissory estoppel which is a doctrine evolved by equity
(and not estoppel) to prevent injustice. This common Judgment
disposes of four Writ Petitions filed by Sun Pharma Laboratory Ltd., the
common Petitioner in all the said Writ Petitions, as common issues are
raised therein. It is the case of the Petitioner that the promised policy
declared by the Central Government (Respondent No. 1) of 100%
excise duty exemption which had persuaded the Petitioner to alter its
position
and
invest
huge
amount
of
money
has
now
been
indiscriminately curtailed giving rise to the present cause of action to
challenge the impugned notifications whittling down the exemption
benefits and resulting in the passing of a series of impugned show
cause
notices
and
impugned
orders
by
the
Central
Excise
Commissionerate confirming demands of Central Excise duties, interest
and penalties thereon.
W.P.(C) No. 41/2015
2.
W.P. (C) No. 41/2015 impugns Notification No. 21/2008-C.E.
dated 27.03.2008 (impugned Notification No.21/2008) and Notification
No.
36/2008-C.E
dated
10.06.2008
(impugned
Notification
No.36/2008) and seeks a prayer for the Petitioner units to be
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
permitted to avail the benefit of exemption of payment of excise duty
as
provided
in
terms
of
Notification
No.
56/2003–C.E
dated
25.06.2003 (Notification No. 56/2003). The said writ Petitions also
impugns Notification No. 20/2008-C.E dated 27.03.2008 (impugned
Notification No. 20/2008) and Notification No. 38/2008-C.E dated
10.06.2008 (impugned Notification No. 38/2008) and seeks a prayer
for the Petitioner units to be permitted to avail the benefit of
exemption from payment of excise duty as provided in terms of
Notification No. 20/2007-C.E dated 25.04.2007 (Notification No.
20/2007).
W.P. (C) No. 08/2017
3.
W.P. (C) No. 08/2017 impugns Order No. M.O/75748-75751/16
& F.O/76277-76280/16 dated 14.12.2016 passed by the Customs,
Excise & Service Tax Appellate Tribunal (CESTAT) in Appeal Nos.
E/76003/15, 75290/16, 75930/14 and 76004/15 by which the CESTAT
came to the view that the constitutional validity of the impugned
Notification No. 21/2008 being in question pending before this Court
the said notification if upheld, the Petitioner would not have any claim
before the CESTAT and if set aside, it would. Thus, holding so, liberty
was granted to the Petitioner to approach the CESTAT again after the
final verdict from this Court.
4.
The said Writ Petition also impugns:(i) OIO No. 10/COMM/CE/SLG/13-14 dated 26.03.2014 issued
on 27.03.2014 passed by the Commissioner of Customs, Central
Excise
and
Service
Tax,
Silliguri
Commissionerate
(the
Commissioner) by which the demand of Central Excise duty
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
amounting to ₹5,17,43,860/- under Section 11 A of the Central
Excise Act, 1944 on the Petitioner, the interest at applicable rate
up to the date of payment of duty on the duty amount
under
Section 11 AB of the Central Excise Act, 1944 as well as the
penalty of ₹5,17,43,860/- under Section 11 AC of the Central
Excise Act, 1944 was confirmed and the self credit facility
available under Notification No. 56/2003-C.E dated 25.06.2003
(Notification No.56/2003) was withdrawn from the Petitioner.
(ii)
OIO
No.06-07/COMM/CE-SLG/15-16
dated
17.07.2015
passed by the Commissioner confirming the demands of Central
Excise duty (i) amounting to ₹5,31,41,422.00 pertaining the
period December 2012 to June, 2013 and (ii) amounting to
₹8,45,18,446/- pertaining to the period July, 2013 to January,
2014 on the Petitioner under the provisions of Section 11 A (4)
of the Central Excise Act, 1944 read with Rule 8 of the Central
Excise Rule, 2002 and sub paragraph 2C (g) of the Notification
No. 56/2003 as amended by impugned Notification No. 21/2008
along with appropriate interest on the amounts confirmed in
terms of Section 11 AB (now 11 AA) of the Central Excise Act,
1944 and the penalty amount of ₹13,76,59,868.00 (Rupees
thirteen crore seventy six lakhs fifty nine thousand eight hundred
sixty eight) (₹5,31,41,422+ ₹8,45,18,446) on the Petitioner in
terms of Section 11 AC (1) (c) of the Central Excise Act, 1944.
However, the Petitioner was given the offer to pay only 25% of
such amount as penalty on fulfilment of the conditions as
prescribed under Section 11 AC (1) (e) of the Central Excise Act,
1944. By the said order the Commissioner also ordered the
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
forfeiture of self credit facility as available to the Petitioner under
the said Notification No. 56/2003 as amended by the impugned
Notification No. 21/2008 in terms of the provision of subparagraph 2C (f) of the said notification.
(iii) OIO No.22/COMM/CE/SLG/15-16 dated 08.01.2016 of the
Commissioner by which he confirmed the demand of central
excise duty (i) amounting to ₹2,27,27,200.00 pertaining to the
month of February 2014 on the Petitioner under the provision of
Section 11 A (1) of the Central Excise Act, 1944 read with Rule 8
of the Central Excise Rule, 2002 and sub-paragraph 2C (g) of the
Notification
No.
56/2003
as
amended
by
the
impugned
Notification No. 21/2008 and the appropriate interest on the said
confirmed amount of duty at appropriate rate in terms of Section
11 AA of the Central Excise Act, 1944 and the penalty amounting
to ₹2,27,27,200.00 on the Petitioner in terms of Section 11 AC
(1) (c) of the Central Excise Act, 1944. However, the Petitioner
was given the offer to pay only 25% of such amount as penalty
on fulfilment of the conditions as prescribed under Section 11 AC
(1) (e) of the Central Excise Act, 1944. By the said order the
Commissioner also ordered the forfeiture of self credit facility as
available to the Petitioner under the said Notification No.
56/2003 as amended by impugned Notification No. 21/2008 in
terms of the provision of sub-paragraph 2C (f) of the said
notification.
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
W.P.(C) No. 27/2017
5.
W.P. (C) No. 27/2017 sought quashing of four show cause
notices issued by the Deputy Commissioner of Central Excise and
Service Tax, Gangtok Division, Siliguri (Deputy Commissioner) as well
as five notifications issued by the Respondent No.1. The details of the
said show cause notices and Notifications are as under:(i)
C.No.V(18)
02/Refund/CE/Sun-754/GTK-Divn/16-17/3184
dated 5.08.2016, issued by the Deputy Commissioner directing
the
Petitioner
to
show
cause
as
to
why
the
refund
of
₹4,62,76,710/-, ₹3,91,50,366/-, ₹5,45,22,707/-,₹2,94,34,399/and ₹3,60,37,967/- for the month of February, 2016, March
2016, April 2016, May 2016 and June 2016 respectively claimed
by the Petitioner in terms of clause 2B (b) of Notification No.
56/2003 should not be rejected and disallowed for not having
fulfilled the condition as stipulated in clause 3 (i) and (ii) of the
said notification.
(ii)
C.No.V
(18)52/Refund/CE/Sun-754/GTK-Divn/16-17/3600
dated 26.08.2016, issued by the Deputy Commissioner directing
the Petitioner to show cause as to why the refund of differential
amount of ₹10,54,60,351/- and ₹6,48,30,249/- for the financial
year 2014-15 and 2015-16 respectively as claimed by the
Petitioner in terms of clause 2.2(1) & (2) of the said Notification
No. 56/2003 should not be rejected and disallowed for not
having fulfilled the condition as stipulated in Clause 3 (i) & (ii) of
the said notification.
(iii)
C.No.V(15)19/ADJ/CE/COMM/SLG/2016/20697
dated
19.10.2016, issued by the office of the Commissioner of
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
Customs, Central Excise & Service Tax, Siliguri directing the
Petitioner
to
show
cause
as
to
why
the
amount
of
₹82,84,25,639/- erroneously refunded in contravention to the
condition as laid down in clause 3 (i) and (ii) of the said
notification read with clause
2B (b) of the said notification
should not be deposited forthwith as undertaken by the
Petitioner to do so in the undertaking submitted to the
department at the time of submitting its refund claim. The said
show cause notice also required the Petitioner to show cause as
to why the said amount, erroneously refunded to the Petitioner,
if not deposited forthwith as per the undertaking, should not be
demanded in terms of Section 11A of the Central Excise Act,
1944. It further required to show cause as to why the interest in
terms of Section 11AA of Central Excise Act, 1944, should not be
demanded.
(iv)
C.No.V(18)58/CE/Refund/Sun-754/GTK-Divn./2016-17/605
dated 20.02.2017, issued by the Deputy Commissioner, directing
the
Petitioner
₹4,49,82,808/-,
₹5,01,55,727/-,
to
show
cause
as
to
₹5,19,93,070/-,
₹1,88,94,680,
why
the
refund
of
₹4,85,03,864/-,
₹5,09,23,261/-
and
₹4,55,74,646/- for the months of July 2016, August 2016,
September 2016, October 2016, November 2016, December
2016 and January 2017 respectively, in total amounting to
₹31,10,28,056/- claimed by the Petitioner in terms of clause
2B(b) of Notification No. 56/2003 should not be rejected and
disallowed for not having fulfilled the condition as stipulated in
clause 3(i) & (ii) of the said notification.
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
(v) Notification No. 27/2004-CE dated 09.07.2004, (impugned
Notification No. 27/2004) issued by the Respondent No.1 further
amending Notification No.56/2003 amongst others.
(vi) Impugned Notification No. 21/2008 which is also impugned
in W.P. (C) No. 41/2015.
(vii) Notification No. 36/2008 C.E dated 10.06.2008, (impugned
Notification No.36/2008) which is also impugned in W. P. (C) No.
41/2015.
(viii) Impugned Notification No. 20/2008-CE which is also
impugned in W. P. (C) No. 41/2015.
(ix) Impugned
Notification No. 38/2008-CE which is also
impugned in W. P. (C) No. 41/2015.
W.P.(C) No. 40/2017
6.
W.P.(C) No. 40/2017 impugns two show cause notices issued by
the Commissioner and two notifications issued by the Respondent
No.1. The details of the said show cause notices and notifications are
as under:(i)
C.No.V(15)20/ADJ/CE/COMM/SLG/2016/24091
dated
02.12.2016, issued by the Commissioner directing the Petitioner
to show cause as to why the Verification Certificates issued by
the Deputy/Assistant Commissioner, Central Excise & Service
Tax, Gangtok Division, bearing No.58 dated 27.11.2015 issued
vide
C.No.V(18)08/CE/SUN/VR/Per14-15/Gtk-Divn/2015-
16/4049-4053
dated
30.11.2015;
No.59
dated
27.11.2015
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
issued
by
C.No.V(18)08/CE/SUN/VR/Per14-15/Gtk-Divn/2015-
16/4044-4048
dated
30.11.2015;
No.60
dated
27.11.2015
issued vide C.No.V(18)08/CE/SUN/VR/Per14-15/Gtk-Divn/201516/4255-4258;
Verification
Certificates
issued
No.01,02,03,04,05,06/Sun-II/2015-16 all dated 27.11.2015 and
No.07
and
08/Sun-II/2015-16
both
dated
22.12.2015
be
considered erroneous and in violation of the provision of
Notification No.56/2003 (as amended). The said show cause
notice also required the Petitioner to show cause as to why the
total re-credit of Rs. 43,98,61,414.00 availed and subsequently
utilized during the period January, 2015 to January, 2016 should
not be disallowed for being irregular and in violation of the
provisions of Notification No.56/2003-CE dt. 25.06.2003, as
amended, in as much as, the same should be disallowed for not
having fulfilled the condition as stipulated in Clause 3(i) & (ii) of
Notification No.56/2003-CE dt. 25.06.2003, as amended. The
said show cause notice also required the Petitioner to show cause
as to why the irregular re-credit availed and utilised by the
Petitioner, amounting to Rs. 43,98,61,414.00 should not be
demanded and recovered in terms of Section 11A of the Central
Excise Act, 1994, as amended, for violating the provisions of
Clause 2C(g) of Notification No.56/2003-CE dt.25.06.2003, as
amended, read with Rule 8 (3) of the Central Excise Rules, 2002.
The said show cause notice further required the Petitioner to
show cause as to why the Interest in terms of Section 11AA of
the Central Excise Act, 1944, as amended should not be
demanded and recovered till the date of deposit of the said
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
amount and Penalty in terms of Section 11 AC 1(a) of the Central
Excise Act, 1944, as amended, should not be imposed on them
for having contravened the provisions of the Central Excise Act,
1944 as amended, issued under Section 5A of the Central Excise
Act,1944 as amended.
(ii)
C.No.V(15)21/ADJ/CE/COMM/SLG/2016/895
dated
13.01.2017, issued by the office of the Commissioner directing
the Petitioner to show cause as to why the total re-credit of
₹15,12,61,747/- availed and subsequently utilized during the
period February, 2016 and March, 2016 should not be disallowed
for being irregular and in violation of the provision of Notification
No.56/2003 as amended and disallowed for not having fulfilled
the condition as stipulated in clause 3(i) and 3(ii) of Notification
No.56/2003 as amended. The said show cause notice also
required the Petitioner to show cause as to why the irregular recredit availed and utilized by the Petitioner, amounting to Rs.
15,12,61,747.00 should not be demanded and recovered in
terms of Section 11A of the Central Excise Act, 1944 (as
amended), for violating the provisions of Clause 2C(g) of
Notification No.56/2003-CE, dt.25.06.2003 as amended, read
with Rule 8(3) of the Central Excise Rules, 2002. The said show
cause notice also required the Petitioner to show cause as to why
the interest in terms of Section 11AA of the Central Excise Act,
1944 as amended should not be demanded and recovered till the
date of deposit of the said amount. The said show cause notice
also required the Petitioner to show cause as to why the penalty
in terms of Section 11AC 1(a) of the Central Excise Act, 1944 as
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
amended,
should
not
be
imposed
on
them
for
having
contravened the provisions of the Central Excise Act, 1944, as
amended, read with Notification No.56/2003-CE dt.25.06.2003,
as amended, issued under Section 5A of the Central Excise Act,
1944, as amended.
(iii) Impugned Notification Nos. 20/2008-CE dated 27.03.2008
which is impugned in W.P. (C) No. 41/2015 and WP (C)
No.27/2017 also.
(iv) Impugned Notification No. 38/2008-CE which is impugned in
W.P.(C) No. 41/2015 and W.P.(C) No.27/2017 also.
7.
At the hearing, Mr. Vikram Nankani, Senior Advocate would
submit that the Petitioner seeks the promotional benefits under the
North East Industrial and Investment Promotion Policy (NEIIPP), 2007
(Industrial Policy, 2007) read with Notification No. 20/2007 by which it
is submitted, 100% of the excise duty was exempted which has now
been reduced to 56% only vide impugned Notifications No. 20/2008
and 21/2008 although the Petitioner had already, in terms of the
promise made, invested huge amounts of money between 2005 to
2008 much prior to the commencement of commercial production of
Petitioner‟s first unit on 20.04.2009.
It is the contention of the
Petitioner that this has been done by the Respondents solely on the
ground that the Petitioner had not opted for the same. The Petitioner
contends that based on the Industrial Policy of 2003 which also
exempted from so much of the duty of excise leviable thereon as is
equivalent to the amount of duty paid by the manufacturer of the
goods other than the amount of duty paid by utilisation of CENVAT
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
credit under the CENVAT Credit Rules, 2002 for a period of 10 years
from the date of commencement of commercial production, the
Petitioner in the year 2005 and thereafter commenced the process of
establishing a new unit for manufacture of P & P Medicaments, falling
under Sl. No. 11 of the schedule to the Notification No. 56/2003
including leasing of the land for establishing the said unit, generating
employment in the State etc. It is the contention of the Petitioner, in
the meanwhile, Office Memorandum dated 01.04.2007 was issued
notifying the Industrial Policy, 2007, which also granted 100% excise
duty exemption as provided in the Industrial Policy, 2003. However,
the Industrial Policy, 2007 specifically provided that the new industrial
units which commenced production within 10 years of the said
memorandum would be eligible for the incentive thereunder. In line
with the Industrial Policy, 2007, Notification No. 20/2007 was issued
whereby the Petitioner‟s goods were exempted from so much of the
duty of excise leviable thereon as is equivalent to the amount of duty
paid by the manufacturer of goods other than the amount of duty paid
by utilisation of CENVAT credit. In the year 2008, the earlier notified
100% excise duty exemption was significantly curtailed by issuing two
amending impugned Notification Nos. i.e. 21/2008 and 20/2008 by
which the benefit of exemption was limited to the certain prescribed
percentage of value addition i.e. 56% applicable to pharmaceutical
products
as
mentioned
in
the
respective
notifications.
Further
amendment to Notifications No. 56/2003 and 20/2007 was made vide
impugned Notification No. 36/2008-CE (which amends Notification No.
56/2003) and impugned Notification No.38/2008 (which amends
Notification No. 20/2007) both dated 10.06.2008 whereby an option
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
for fixation of special rates for representing the actual value addition in
respect of any goods manufactured and cleared under the respective
original notification was given. The Petitioner‟s first unit commenced
commercial production from 20.04.2009 and the second unit from
14.04.2014. The Petitioner submits that although it was eligible to get
the
benefit
inadvertently,
of
exemption
after
under
commencing
the
Industrial
commercial
Policy,
2007,
production
from
20.04.2009 the Petitioner started claiming excise duty benefit pursuant
to the Industrial Policy, 2003 by way of self-credit of excise duty in
cash for the period April, 2009 to May, 2012 at the reduced rate of
56% instead of 100% of the amount paid in cash. No objection has
been taken to this credit taken by the Petitioner. Subsequently,
however the Petitioner became aware of the decision of this Court in
re:
Unicorn
Industries
v.
U.O.I1,
wherein
this
Court
quashed
Notification No. 23/2008 and Notification No. 37/2008 which had
similarly, curtailed benefits promised under Industrial Policy, 2003. It
is the case of the Petitioner that it further became aware of the
decision of the High Court of Jammu & Kashmir in re: Reckitt
Benckiser v. Union of India2, wherein the High Court of Jammu and
Kashmir had quashed the amending notifications seeking to reduce
and restrict the 100% duty exemption provided pursuant to an
incentive scheme for Jammu and Kashmir. Thereafter, on 22.10.2011,
the Petitioner informed the authorities that it would avail 100% selfcredit of the excise duty paid placing reliance on the aforesaid
Judgments of this Court and the High Court of Jammu and Kashmir.
For the period June, 2012 to February, 2014 the authorities denied
2013 (289) E.L.T 117 (Sikkim)
2011 (269) E.L.T 194
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
self-credit on monthly basis on the ground that the Petitioner was not
eligible to claim the benefit @ 100% of the amount paid in cash but
was eligible for refund @ 56% on account of the amendment vide
impugned Notification No. 21/2008 which reduced the benefit from
100%. It is the case of the Petitioner that it has invested an amount
of ₹186.08 crores up to March 2014 and being a large project
investment continued thereafter and an amount of ₹337.51 crores
have been invested up to March 2016.
8.
Mr. Vikram Nankani, learned Senior Advocate for the Petitioner
would argue that the Petitioner had acted on the basis of the promise
set out in the Industrial Policy, 2003 and 2007 and the original
Notification
No.20/2007
which
was
amended
by
the
impugned
Notifications No. 20/2008 and 21/2008 reducing the 100% excise duty
guarantee to 56% by making huge investment and therefore, on the
ground of promissory estoppel alone the Writ Petitions were liable to
be
allowed
and
the
offending
notifications
and
orders
of
the
Commissionerate quashed. He would further submit that merely
because power to issue notification is available, the authority cannot,
be permitted to equate what is inherently not equal. He would submit
that once an exemption notification has been issued in public interest
the authority cannot, by simply saying it is in public interest, withdraw
or reduce the benefit under the original notification and in such cases,
the onus shall be on the authority to establish a superior public
interest for curtailing or withdrawing an exemption already granted.
Mr. Vikram Nankani, learned Senior Advocate would rely upon the
following judgments in support of his submissions on area based
exemption, promissory estoppel and on his submission that benefit
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
cannot be denied due to claim under wrong notification: (1) Sal Steel
Ltd. V. UOI3, (2) Unicorn Industries v. U.O.I (supra), (3) Reckitt Benckiser v.
U.O.I, (4) Herbo Foundation Pvt. Ltd. V. U.O.I 4, (5) Manuel Sons Hotel Pvt.
Ltd. V. State of Kerala5, (6) State of Jharkhand v. Tata Cummins6, (7) Shiva
Shakti sugars Ltd. V. Shree Renuka Sugar7, (8) Unichem Laboratories v.
Collector of CE8, (9) Share Medical Care v. U.O.I9 and (10) Hero Cycles Ltd. V.
U.O.I10
9.
The Respondents however, defend their action and submit that
in fact the impugned notifications does not actually take away the
100% excise duty benefit as sought to be made out by the Petitioner.
It is claimed that a different mechanism was devised in public good
and that impugned Notification No. 20/2008 does not deviate from the
100% policy. Mr. Kaushik Chanda, learned Additional Solicitor General
would submit that in spite of the new mechanism devised, ultimately
the benefit to the Petitioner would be 100% exemption. To explain the
same the learned Additional Solicitor General for the Respondents
would place two separate calculations of re-credit / refund under area
based exemption notification as under:“CALCULATION OF RE-CREDIT/REFUND UNDER AREA BASED EXEMPTION NOTIFICATION
100% re-credit/ refund case (Not No. 20/2007):
Value of the
finished
goods
₹100
Duty @
6%
Input cost
Input credit
@ 12%
₹6
₹22
₹2.64
Duty
payment
from PLA/account
current
₹6-₹2.64 = ₹3.36
100%
recredit/refund
₹3.36
Re-credit/Refund as per value addition (Not no. 20/2008):-
Value
of
the
finished
goods
Duty
@ 6%
2010 (260) ELT 185 (Guj)
2010 (261) ELT 98 (Gau)
(2016) SCC 766
(2006) 4 SCC 57
(2017) SCC 729
2002 (145) ELT 502 (SC)
2007 (209) ELT 321 (SC)
2009 (ELT) 490 (Bom)
Input
cost
Input credit
@ 12%
Duty payment
from
PLA/account
current
Value
addition
@ 56%
on total
100%
recredit/refund
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
₹100
₹6
₹22
₹2.64
₹6-₹2.64=
₹3.36
duty
₹3.36
₹3.36
”
10.
The Respondents would admit that the Petitioner started
industrial production w.e.f. 20.04.2009 but would contest the assertion
of the Petitioner that the new unit of the Petitioner was started within
the period 2005-2008. The Respondents submits that the Petitioner fell
within category (a) of paragraph 3 of Notification No. 56/2003 because
the Petitioner started investment on or after 23rd December, 2002 i.e.
from 2005. The Respondents submits that the Petitioner is entitled
only to a limited claim from exemption of central excise duty vide
impugned Notification No. 21/2008 since the Petitioner started
commercial production from 20.04.2009. The Respondents asserts that
the Petitioner had started availing credit of the amount of duty paid
other than by way of utilisation of CENVAT credit under the CENVAT
Credit Rules, 2004 @ 56% right from the beginning. It is denied that
the Petitioner was granted 100% self credit of the amount of duty
paid. It is further stated that the Petitioner started paying central
excise duty from personal ledger account w.e.f. August 2009 by which
time impugned Notifications No. 21/2008 and 36/2008 were already in
existence. The Respondents would submit that the Respondent No.1
was empowered under Section 5A of the Central Excise Act, 1944 to
grant exemption from duty of excise if the Government is satisfied that
it is necessary and “in public interest so to do by a Notification in
official gazette.‖ The Respondents would further submit that the
Petitioner was duly entitled to claim the option for fixation of special
rate on the basis of impugned Notification No.36/2008.
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
11.
The learned Additional Solicitor General would submit that the
Respondent No.1 had the power to issue the notifications sought to be
assailed and if the said notifications were stated to be in public interest
the onus would lie on the challenger to show how it was not in public
interest. The learned Additional Solicitor General would fairly concede
that, what was the public interest which compelled the Respondent
No.1 to issue the offending notifications has however neither been
specified in the offending notifications or explained in the counteraffidavit filed.
12.
He would rely upon the following Judgments in support of his
defence of the impugned notifications:(1) Modipon Limited & Anr. v. Union of India & Ors.,11 (2) Kothari
Industrial Corpn. Ltd. v. T.N. Electricity Board 12, (3) DG of Foreign
Trade v. Kanak Exports13 and (4) R.C. Tobacco (P) Ltd. v. Union of
India14.
13.
In rejoinder, Mr. Vikram Nankani, learned Senior Advocate for
the Petitioner would submit that the chart set out by the learned
Additional Solicitor General for the Respondents is flawed because
whereas the previous notification provided 100% exemption from
Excise Duty the offending notifications sought to curtail the same by
limiting the exemption to 56% only to the duty payable on value
addition undertaken in the manufacture of the goods and not on the
entire excise duty payable as promised. The attention of the Court was
drawn to the explanation to clause 3(4) of the impugned Notification
No. 20/2008 which provides:
“..................
2002 (146)ELT 45 (Del.)
(2016) 4 SCC 134
(2016) 2 SCC 226
(2005) 7 SCC 725
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
Explanation: For the purpose of this paragraph, the actual value addition in
respect of said goods shall be calculated on the basis of the financial records of
the preceding financial year, taking into account the following:
(i) Sale value of the said goods excluding excise duty, Value Added Tax and
other indirect taxes, if any, paid on the goods;
(ii) Less: Cost of raw materials and packing material
consumed in the said goods;
(iii) Less: Cost of fuel consumed if eligible for input credit under CENVAT
Credit Rules, 2004;
(iv) Plus : Value of said goods available as inventory in the unit but not
cleared, at the end of the financial year;
(v) Less: Value of said goods available as inventory in the unit but not
cleared, at the end of the financial year preceding that under
consideration.
Special rate would be the ratio of actual value addition in the production or
manufacture of the said goods to the sale value of the said goods excluding
excise duty, Value Added Tax and other indirect taxes, if any, paid on the
goods.
(5) The manufacturer shall be entitled to refund at the special rate fixed
under sub-paragraph (2) in respect of all clearances of excisable goods
manufactured and cleared under this notification with effect from the date on
which the application referred to at sub-paragraph (1) was filed with the
Commissioner of Central Excise or Commissioner of Central Excise and
Customs, as the case may be.
(6) Where a special rate is fixed under sub-paragraph (2), the refund
payable in a month shall be equivalent to the amount calculated as a
percentage of the total duty payable on such excisable goods, at the rate so
fixed.
Provided that the refund shall not exceed the amount of duty paid on such
goods, other than by utilization of CENVAT credit.”
The facts
14.
The Petitioner was initially a partnership which was subsequently
converted into a private Limited Company incorporated under the
Companies Act, 1956 and merged with Sun Pharma Laboratories
Limited, having its factory at plot no.754, Setipool, P.O. Rangpo, East
Sikkim.
The
Petitioner
holds
Central
Excise
Registration
No.AARCS9750KEM003 and is, inter alia, engaged in the manufacture
of P & P Medicament falling under chapter heading no.3004.
15.
For the development of industries in Sikkim, the Respondent
No.1 notified the “New Industrial Policy and other concessions for the
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
State
of
Sikkim”
(Industrial
Policy,
2003)
vide
Memorandum
No.14(2)/2002-SPS notified on 17.02.2003 inter-alia granting 100%
exemption from excise duty for a period of 10 years from the date of
commencement of commercial production. It was stated, keeping in
view the fact that the State of Sikkim lags behind in Industrial
development, a need has been felt for structured interventionist
strategies to accelerate industrial development of the State and to
boost Investor confidence. It was also stated that the new incentives
would provide required incentives as well as an enabling environment
for industrial development, improve availability of capital and increase
market access to provide a fillip to the private investment in the State.
The relevant paragraph 3.1 read thus:“3.1 Fiscal incentives to new Industrial Units and substantial expansion of
existing units:
i. i.) New industrial units and existing industrial units on their substantial
expansion as defined, set up in Growth Center, Industrial Infrastructure
Development Centers (IIDCs) and other locations like Industrial Estates,
Export Processing Zones, Food Parks, IT Parks, etc. as notified by the Central
Government are entitled to 100% (hundred percent) income tax and
excise duty exemption for a period of 10 years from the date of
commencement of commercial production. Thrust Sector Industries as
mentioned in Annexure–II are entitled to similar concessions in the entire
State of Sikkim without area restrictions.”
[Emphasis supplied]
16.
Notification No. 56/2003 was issued by the Respondent No.1 by
which the 100% excise duty exemption under Industrial Policy, 2003
was operationalized. The relevant preamble of the said Notification
No.56/2003 was as under:“In exercise of the powers conferred by sub-section (1) of section 5A of the
Central Excise Act, 1944 (1 of 1944), read with sub-section (3) of section 3 of
the Additional Duties of Excise (Goods of Special Importance) Act, 1957 (58 of
1957) and sub-section (3) of section 3 of the Additional Duties of Excise
(Textiles and Textile Articles) Act, 1978 (40 of 1978), the Central
Government, being satisfied that it is necessary in the public interest so to do,
hereby exempts the goods specified in the Schedule appended hereto, other
than goods specified in Annexure appended hereto, and cleared from a unit
located in the State of Sikkim, from so much of the duty of excise
leviable thereon under any of the said Acts as is equivalent to the
amount of duty paid by the manufacturer of goods other than the
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
amount of duty paid by utilization of CENVAT Credit Rules, 2002.”
[Emphasis Supplied]
17.
Paragraph 3 and 4 of Notification No. 56/2003 read as under:“3. The exemption contained in this notification shall apply only to the
following kind of units namely:(a) new industrial units which have commenced their commercial
production on or after the 23rd day of December, 2002.
(b) industrial units existing before the 23 rd day of December, 2002, but
which have undertaken substantial expansion by way of increase in
installed capacity by not less than twenty five per cent on or after
23rd day of December, 2002.
4.
The exemption contained in this notification shall apply to any of
the said units for a period not exceeding ten years from the date of
publication of this notification in the Official Gazette or from the date
of commencement of commercial production whichever is later.‖
[Emphasis Supplied]
18.
On
09.07.2004
the
Respondent
No.1
issued
impugned
Notification No. 27/2004 by which paragraph 3 of the Notification No.
56/2003 was substituted with the following paragraph:“3. The exemption contained in this notification shall apply only to the
following kinds of units, namely:(i)
new industrial units which have commenced commercial
production on or after the 23rd day of December, 2002, but not
later than the 31st day of March, 2007.
(ii) industrial units existing before the 23 rd day of December, 2002,
but which have undertaken substantial expansion by way of
increase in installed capacity by not less than twenty five per
cent on or after the 23rd day of December 2002, but have
commenced commercial production from such expanded
capacity, not later than the 31st day of March, 2007.”
19.
The Respondent No.1 vide the said Notification No. 27/2004 thus
restricted the date of commencement of commercial production which
was open ended earlier to the period 23.12.2002 till 31.03.2007.
20.
On 01.04.2007 vide an office memorandum the Respondent No.1
notified the Industrial Policy, 2007. The Industrial Policy, 2003 was
discontinued on and from 01.04.2007. This Industrial Policy, 2007
covered the State of Sikkim as well. In the said Industrial Policy, 2007
it was provided:-
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
“(ii) Duration:
all new units as well as existing units which go in for substantial expansion,
unless otherwise specified and which commence commercial production within
the 10 year period from the date of notification of NEIIPP, 2007 will be eligible
for incentives for a period of ten years from the date of commencement of
commercial production.
.....................
....................
(v) Excise Duty Exemption:
100% Excise Duty exemption will be continued, on finished products made
in the North Eastern Region, as was available under NEIP, 1997. However, in
cases, where the CENVAT paid on the raw materials and intermediate
products going into the production of finished products (other than the
products which are otherwise exempt or subject to nil rate of duty) is higher
than the excise duties payable on the finished products, ways and means to
refund such overflow of CENVAT credit will be separately notified by the
Ministry of Finance.”
21.
The Respondent No.1 issued
Notification No. 20/2007 giving
effect to the Industrial Policy, 2007 by which it was provided :―In exercise of the powers conferred by sub-section (1) of the section 5A of
the Central Excise Act, 1944 (1 of 1944), the Central Government, being
satisfied that it is necessary in the public interest so to do, hereby exempts
the goods specified in the First Schedule to the Central Excise Tarrif Act, 1985
(5 of 1986) other than those mentioned in the Annexure and cleared form a
unit located in the States of Assam or Tripura or Meghalaya or Mizoram or
Manipur or Nagaland or Arunachal Pradesh or Sikkim, as the case may be,
from so much of the duty of excise leviable thereon under the said Act
as is equivalent to the amount of duty paid by the manufacturer of
goods other than the amount of duty paid by utilisation of CENVAT
credit under the CENVAT Credit Rules, 2004.‖
[Emphasis Supplied]
22.
The exemption contained in Notification No.20/2007 was to be
given effect to in the manner provided under paragraph 3 thereof.
Under paragraph 5 of the said Notification No.20/2007 the exemption
was to apply to:“(a) New Industrial units which commence commercial production on or after
the 1st day of April, 2007 but not later than 31st day of March, 2017;
(b) Industrial units existing before the 1st day of April, 2007 but which have
undertaken substantial expansion by way of increase by not less than 25% in
the value of fixed capital investment in plant and machinery for the purposes
of expansion of capacity/modernization and diversification and have
commenced commercial production from such expanded capacity on or after
the 1st day of April, 2007 but not later than 31st day of March, 2017”.
23.
The Respondent No.1 vide impugned Notification No. 21/2008 in
exercise of the powers conferred by sub-section (1) of Section 5A of
the Central Excise Act, 1944, read with sub-section (3) of Section 3 of
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
the Additional Duties of Excise (Goods of Special Importance) Act,
1957 and sub-section (3) of Section 3 of the Additional Duties of
Excise
(Textile
and
Textile
Articles)
Act,
made
further
amendments to Notification No.56/2003. The Preamble was amended.
In the Preamble, for the words and figures, ―to the amount of duty
paid by the manufacturer of goods other than the amount of duty paid
by utilisation of CENVAT credit under the CENVAT Credit Rules, 2002‖,
the words ―to the duty payable on value addition undertaken in the
manufacture of the said goods by the said unit‖ were substituted.
Paragraphs 1A, 2 and 2A of Notification No. 56/2003 was substituted
with new paragraphs 2, 2A, 2B, 2C and 2.1.
24.
The Respondent No.1 vide impugned in exercise of the powers
conferred by sub-section (1) of Section 5A of the Central Excise Act,
1944, amended Notification No.20/2007. In the Preamble, for the
words and figures, ―to the amount of duty paid by the manufacturer of
goods other than the amount of duty paid by utilisation of CENVAT
credit under the CENVAT Credit Rules, 2004”, the words ―to the duty
payable on value addition undertaken in the manufacture of the said
goods by the said unit‖ were substituted. Paragraphs 2, 3 and 4 of
Notification No. 20/2007 were substituted with new paragraphs 2A,
2B, 2C, 2D and 3. The new paragraph 2A to the said impugned
Notification No. 20/2008 read as follows:“2A. The duty payable on value addition shall be equivalent to the
amount calculated as a percentage of the total duty payable on the said
excisable goods of the description specified in column (3) of the Table below
(hereinafter referred to as the said Table) and falling within the Chapter of the
said First Schedule as are given in the corresponding entry in column (2) of
the said Table, at the rates specified in the corresponding entry in column (4)
of the said Table:
Sl.
No.
(1)
Chapter of the First
Schedule
(2)
Description
goods
(3)
of
Rate
(4)
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
---30
-------------------------------
---All goods
-------------------------------
---56
-------------------------------
Provided that where the duty payable on value addition exceeds the
duty paid by the manufacturer on the said excisable goods, other than the
amount paid by utilization of CENVAT credit during the month, the duty
payable on value addition, shall be deemed to be equal to the duty so paid
other than by CENVAT credit.”
25.
Paragraph 3 of impugned Notification No. 20/2008 provided:“3. (1) Notwithstanding anything contained in paragraph 2A, the
manufacturer shall have the option not to avail the rates specified in the said
Table and apply to the Commissioner of Central Excise or the Commissioner of
Customs and Central Excise, as the case may be, having jurisdiction over the
manufacturing unit of the manufacturer for fixation of a special rate
representing the actual value addition in respect of any goods manufactured
and cleared under this notification, if the manufacturer finds that four-fifths of
the ratio of actual value addition in the production or manufacture of the said
goods to the value of the said goods, is more than the rate specified in the
said Table expressed as a percentage. For the said purpose, the manufacturer
may, within sixty days from the beginning of a financial year, make an
application in writing to the Commissioner of Central Excise or the
Commissioner of Customs and Central Excise, as the case may be, for
determination of such special rate, stating all relevant facts including the
proportion in which the materials or components are used in the production or
manufacture of goods:
Provided that the Commissioner of Central Excise or the Commissioner of
Customs and Central Excise may, if he is satisfied that the manufacturer was
prevented by sufficient cause from making the application within the aforesaid
time, allow such manufacturer to make the application within a further period
of thirty days :
Provided further that the manufacturer supports his claim for a special rate
with a certificate from his statutory auditor containing an estimate of value
addition in the case of goods for which a claim is made, based on the audited
balance sheet of the unit, for the preceding financial year;
(2) On receipt of the application referred to in sub-paragraph (1), the
Commissioner of Central Excise or Commissioner of Customs and Central
Excise, as the case may be, after making or causing to be made such inquiry
as he deems fit, shall fix the special rate within a period of six months of such
application;
(3) Where the manufacturer desires that he may be granted refund
provisionally till the time the special rate is fixed, he may, while making the
application, apply to the Commissioner of Central Excise or the Commissioner
of Customs and Central Excise, as the case may be, in writing for grant of
provisional refund at the rate specified in column (4) of the said Table for the
goods of description specified in column (3) of the said Table and falling in
Chapter of the First Schedule of the Central Excise Tariff Act, 1985 (5 of
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
1986) as in corresponding entry in column (2) of the said Table, and on
finalization of the special rate, necessary adjustments be made in the
subsequent refunds admissible to the manufacturer in the month following the
fixation of such special rate.
(4) Where the Central Government considers it necessary so to do, it may –
(a) revoke the special rate or amount of refund as determined under subparagraph (2) by the Commissioner of Central Excise or the Commissioner of
Customs and Central Excise, as the case may be, or
(b) direct the Commissioner of Central Excise or the Commissioner of
Customs and Central Excise, as the case may be, to withdraw the rate so
fixed.
Explanation : For the purpose of this paragraph, the actual value addition in
respect of said goods shall be calculate on the basis of the financial records of
the preceding financial year, taking into account the following :
(i)
Sale value of the said goods excluding excise duty, Value Added Tax
and other indirect taxes, if any, paid on the goods;
(ii)
Less : Cost of raw materials and packing material consumed in the
said goods;
(iii)
Less : Cost of fuel consumed if eligible for input credit under CENVAT
Credit Rules, 2004;
(iv)
Plus : Value of said goods available as inventory in the unit but not
cleared, at the end of the financial year;
(v)
Less : Value of said goods available as inventory in the unit but not
cleared, at the end of the financial year preceding that under consideration.
Special rate would be the ratio of actual value addition in the production or
manufacture of the said goods to the sale value of the said goods excluding
excise duty, Value Added Tax and other indirect taxes, if any, paid on the
goods.
(5)
The manufacturer shall be entitled to refund at the special rate fixed
under sub-paragraph (2) in respect of all clearances of excisable goods
manufactured and cleared under this notification with effect from the date on
which the application referred to at sub-paragraph (1) was filed with the
Commissioner of Central Excise or Commissioner of Central Excise and
Customs, as the case may be.
(6)
Where a special rate is fixed under sub-paragraph (2), the refund
payable in a month shall be equivalent to the amount calculated as a
percentage of the total duty payable on such excisable goods, at the rate so
fixed:
Provided that the refund shall not exceed the amount of duty paid on such
goods, other than by utilization of CENVAT credit.
2. This notification shall come into force with effect from the 1st day of April,
2008.”
26.
The
Respondent
No.1
vide
impugned
Notification
No.
36/2008 in exercise of the powers conferred by sub-section (1) of
Section 5A of the Central Excise Act, 1944, read with sub-section (3)
of Section 3 of the Additional Duties of Excise (Goods of Special
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
Importance) Act, 1957 and sub-section (3) of Section 3 of the
Additional Duties of Excise (Textile and Textile Articles) Act, 1978
made further amendments to Notification No.56/2003 and notified
further conditions whereby an assessee could apply to the Appropriate
Authority for a specific rate for value addition.
27.
The
Respondent
No.1
vide
impugned
Notification
No.
38/2008 in exercise of the powers conferred by sub-section (1) of
Section 5A of the Central Excise Act, 1944 made further amendments
to Notification No.20/2007. The impugned Notification No.38/2008
which further amends the new paragraph 2A as inserted by impugned
Notification No. 20/2008 provides now that ―the duty payable on value
addition shall be equivalent to the amount calculated as a percentage
of the total duty payable on the said excise goods of the description
specified in column (3) of the Table below (hereinafter referred to as
the said Table) and falling within the chapter of the first schedule as
are given in the corresponding entry in column (2) of the said Table
when
manufactured starting from inputs specified in the
corresponding entry in column (5) of the said Table in the same
factory, at the rates specified in the corresponding entry in column
(4) of the said Table.‖ The Table provided in the new paragraph 2A
vide impugned Notification No. 20/2008 to Notification No. 20/2007
has also been replaced with a new Table vide impugned Notification
No. 38/2008. The said Table is as under:Sl.
No.
Chapter of
the
First Schedule
Description
goods
(1)
(2)
1.
.....
of
Rate
Description
of
inputs
for
manufacture of
goods
in
column (3)
(3)
(4)
(5)
.....
.....
.....
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
2.
All goods
Any goods
3.
.....
.....
.....
.....
4.
.....
.....
.....
.....
5.
.....
.....
.....
.....
6.
.....
.....
.....
.....
7.
.....
.....
.....
.....
8.
.....
.....
.....
.....
9.
.....
.....
.....
.....
10.
.....
.....
.....
.....
11.
.....
.....
.....
.....
12.
.....
.....
.....
.....
13.
.....
.....
.....
.....
.....
.....
.....
.....
28.
The
impugned
Notification
No.
38/2008
further
amended
paragraph 3 of the Notification No. 20/2007 as amended by impugned
Notification No.20/2008 and substituted sub-paragraph (1) of the said
paragraph 3 with the following:“(1) Notwithstanding anything contained in paragraph 2A, the manufacturer
shall have the option not to avail the rates specified in the said Table and
apply to the Commissioner of Central Excise or the Commissioner of Customs
and Central Excise, as the case may be, having jurisdiction over the
manufacturing unit of the manufacturer for fixation of a special rate
representing the actual value addition in respect of any goods manufactured
and cleared under this notification, if the manufacturer finds that the actual
value addition in the production or manufacture of the said goods is at least
115 percent of the rate specified in the said Table and for the said purpose,
the manufacturer may make an application in writing to the Commissioner of
Central Excise or the Commissioner of Customs and Central Excise, as the
case may be, not later than the 30th day of September in a financial year for
determination of such special rate, stating all relevant facts including the
proportion in which the materials or components are used in the production or
manufacture of goods :
Provided that the Commissioner of Central Excise or the Commissioner
of Customs and Central Excise, as the case may be, may, if he is satisfied that
the manufacturer was prevented by sufficient cause from making the
application within the aforesaid time, allow such manufacturer to make the
application within a further period of thirty days :
Provided further that the manufacturer supports his claim for a special
rate with a certificate from his statutory auditor containing a calculation of
value addition in the case of goods for which a claim is made, based on the
audited balance sheet of the unit for the preceding financial year;
Provided also that a manufacturer that commences commercial
production on or after the 1st day of April, 2008 may file an application in
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
writing to the Commissioner of Central Excise or the Commissioner of
Customs and Central Excise, as the case may be, for the fixation of a special
rate not later than the 30th day of September of the financial year subsequent
to the year in which it commences production.”
29.
the
Pursuant to the said impugned Notification No. 36/2008,
Department
of
Central
Excise
vide
letter
bearing
No.C.No.V(30)01/CE/SPS/GTK/2009/528 dated 14.12.2011 informed
the Petitioner that they were not eligible for 100% self credit and
requested certain information in this respect. The Petitioner provided
the required information vide letter dated 05.07.2012 and also
informed that they have started taking 100% self credit from the
month of June, 2012 to November, 2012. On the said background
show cause notice No.V(15)13/ADJ/CE/COM/SLG/2012/26125 dated
31.03.2013 came to be issued to the Petitioner calling upon them to
show cause as to why central excise duty amounting to ₹5,17,43,860/being the amount excess re-credited wrongly by the Petitioner and
utilised for payment of excise duty should not be collected in terms of
Section 11 of the Central Excise Act, 1944 for violating the provisions
of Section 11A of the Central Excise Act, 1944 read with Rule 8(3) of
the Central Excise Rules, 2002. Further the show cause notice also
required the Petitioner to show why the interest as per Section 11AB of
the Central Excise Act, 1944 and the penalty under Section 11AC of
the Central Excise Act, 1944 for contravening Rule 8(3) of the Central
Excise Rules, 2002, with a clear intent to evade payment of duty,
should not be imposed. The said show cause notice also required
Petitioner to show cause as to why re-credited facility available under
Notification No.56/2003 should not be disallowed. Although personal
hearing was granted to the Petitioner on three dates the Petitioner‟s
consultant having another pre-schedule hearing could not attend the
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
hearing
or
submit
the
defence
reply
pursuant
to
which
the
Commissioner adjudicated the show cause notice dated 31.03.2013
and passed the impugned OIO No.10/COMM/CE/SLG/13-14 dated
26.03.2014 issued on 27.03.2014.
Being aggrieved by the said
impugned order dated 26.03.2014 the Petitioner preferred an appeal
before the CESTAT, along with an miscellaneous application for the
waiver of pre-deposit and stay of the operations of the said order. The
CESTAT vide order dated 21.11.2014 granted an unconditional stay to
the Petitioner against the recovery duty demanded, interest and
penalty imposed relying upon the judgment of this Court in the matter
of Unicorn Industries (supra). While the appeal was pending final
adjudication and notwithstanding the stay granted, the Department of
Central Excise issued multiple show cause notices to the Petitioner for
different periods and the case of the said Department in those
subsequent show cause notices were identical to the case of the said
Department which was stayed by the CESTAT by the order dated
21.11.2014.
The said show cause notices were (i) SC Notice
No.V(15)07/ADJ/CE COMM/SLG/2013/17243 for the period December
to
June
(ii)
SC
Notice
No.
V(15)09/ADJ/CE/COMM/SLG/14/11061 for the period July 2013 to
January
and
(iii)
SC
Notice
No.
V(15)20/ADJ/CE/COMM/SLG/2014/1863 for the period February 2014.
30.
Thus Writ Petition (C) No. 41 of 2015 was filed challenging the
various impugned Notifications as detailed above.
31.
to
By an Order dated 28.07.2016 this Court directed the CESTAT
examine
(i)
Appeal
No.
E/75930/2014-DB;
(ii)
Appeal
No.
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
E/76003/2015; (iii) Appeal No. E/76004/2016 and (iv) Appeal No.
E/75290/2016 filed by the Petitioner and to take decision by reasoned
order on his own merit, in accordance with law, at the earliest,
preferably within a period of two months. The said Writ Petition was
directed to be listed on receipt of the order rendered by the CESTAT.
32.
On 21.11.2016 this Court granted further period of three
months to CESTAT for disposal of the appeals.
33.
Between the periods 05.08.2016 to 20.02.2017 four show cause
notices were issued for the total period March 2014 to January 2017
seeking to demand and recover 100% benefit on the ground that
Notification No.56/2003 is not applicable because the first unit of the
Petitioner started production on 20.04.2009.
34.
It is the case of the Petitioner that the benefit at the rate of
56% was granted for the period March 2014–August 2015 without any
objection.
It is the further case of the Petitioner that for the period
September 2015 – January 2016 benefit @ 56% was given under
Notification No.20/2007 without objection. No benefit has been
extended from February 2016 till date in respect of the first unit of the
Petitioner. It is the Petitioner‟s case that although all the four show
cause notices admit that the Petitioner is eligible for benefit under
Notification No.20/2007 but seek to deny the same on the ground that
the Petitioner did not opt for the same. In all refund applications made
after August 2016, reference has been made to both Notification
No.56/2003 as well as Notification No.20/2007.
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
35.
W.P. (C) No. 8 of 2017 was preferred on 20.02.2017 by the
Petitioner seeking a writ of certiorari to quash and set aside the
impugned order of the CESTAT dated 14.12.2016 as detailed above.
36.
W.P. (C) No. 27/2017 was preferred on 18.04.2017 by the
Petitioner to challenge four show cause notices issued by the Assistant
Commissioner seeking to reject their refund claims of the Petitioner for
the months of July 2016 to January 2017 pursuant to the order passed
by the CESTAT dated 14.12.2016 and the impugned notifications as
detailed above.
37.
On 19.04.2017 the Petitioner wrote a letter to the Assistant
Commissioner to keep the adjudication of the four notices in abeyance
until the disposal of W.P. (C) No.27 of 2017.
38.
On 12.05.2017 the Assistant Commissioner confirmed the
demand in respect of show cause notice dated 26.08.2016. The
Petitioner therefore filed I.A. No. 1 of 2017 in W.P. (C) No. 27 of 2017
on 13.06.2017 seeking to amend and bring on record the order dated
12.05.2017 passed by the Assistant Commissioner.
39.
On 02.12.2016 and 13.01.2017 two show cause notices were
issued for the period January 2015–March 2016 in respect on second
unit seeking to deny the 100% benefit.
40.
It is the case of the Petitioner that notwithstanding these two
notices, benefit @ 56% has been granted from January 2015 to March
2017. For the period April 2014 when production commenced until
December 2014 no refund application was filed since the Petitioner
started paying excise duty in cash only from January 2015. For the
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
period prior thereto, the Petitioner had sufficient CENVAT credit
amount for payment of excise duty.
41.
W.P.(C) No.40/2017 filed on 21.06.2017 challenges the said
two show cause notices issued by the Commissioner being (i)
C.No.V(15)20/ADJ/CE/COMM/SLG/2016/24091 dated 02.12.2016 and
(ii)
C.No.V(15)21/ADJ/CE/COMM/SLG/2016/895
dated
13.01.2017.
The said Writ Petition also seeks a writ of Certiorari to quash and set
aside impugned Notification No. 20/2008 and Notification No. 38/2008.
Consideration
42.
It is the case of the Petitioner that the Petitioner started
investing for setting up its first unit from the year 2005 only. Evidently
therefore, the Petitioner had started the investment only after issuance
of
impugned
Notification
No.
27/2004
amending
Notification
No.56/2003 which notification put into operation the Industrial Policy,
2003. The said Notification is cogent and clear. The Petitioner does not
fall in any of the two categories of units as mentioned therein. On the
date of the said impugned Notification No.27/2004 the Petitioner was
aware that the exemption of payment of excise duty as per Notification
No.56/2003 as amended would be available to it only on fulfilling the
criteria laid down. To enjoy the benefit of the said Notification
No.56/2003 as amended by impugned Notification No.27/2004 it was
incumbent upon the Petitioner to meet the required criteria of having
commenced commercial production on or after 23.12.2002 but not
later than 31.03.2007. It is not the case of the Petitioner that in the
interregnum between the issuance of Notification No. 56/2003 and
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
impugned Notification No.27/2004 the Petitioner had already started
altering its position. It is neither pleaded nor argued.
43.
As per the Industrial Policy, 2007, the Petitioner having
admittedly started its commercial production on and from 20.04.2009
for its first unit i.e., within the 10 years period from the date of
issuance of memorandum declaring the Industrial Policy, 2007 i.e.,
01.04.2007 was eligible for incentives for a period of 10 years from the
date
of
commencement
of
commercial
production
i.e.,
from
20.04.2009 till 20.04.2019.
44.
The Industrial Policy, 2007 had declared that 100% excise duty
exemption will be continued on finished products made in the North
Eastern Region as was available under the Industrial Policy, 1997.
However, in cases, where the CENVAT paid on the new materials and
intermediate products going into the production of finished goods
(other than the products which are otherwise exempt or subject to nil
rate of duty) is higher than the excise duties payable on the finished
products, ways and means to refund such overflow of CENVAT credit
will be separately notified by the Respondent No.1.
45.
Notification No. 20/2007 provided for exemption of goods
cleared from unit located in the State of Sikkim from so much of the
duty of excise leviable thereon under the Central Excise Act, 1944 as is
equivalent to the amount of duty paid by the manufacturer of goods
other than the amount of duty paid by utilisation of CENVAT Credit
Rules, 2004.
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
46.
It is quite clear that when the Industrial Policy, 2007 was
declared on 01.04.2007 which was followed by the issuance of the
Notification No. 20/2007, the Petitioner had already started investing,
as per the Petitioner, from the year 2005 itself. The exemption
provided for in Notification No.20/2007 would be available to new
industrial unit which commence commercial production on or after
01.04.2007 but not later than 31.05.2017. It would also apply to those
industrial units existing before 01.04.2007 but which have undertaken
substantial expansion by way of increase by not less than 25% in the
value of fixed capital investment in plant and machinery for the
purpose of expansion on capacity/modernization and diversification
and have commenced commercial production from such expanded
capacity on or after 01.04.2007 but not later than 31.05.2017. The
exemption contained in Notification No.20/2007 were to apply to any
of the said units for a period not exceeding 10 years from the date of
publication of the said notification or from the date of commercial
production whichever is later.
47.
The crucial question which must necessarily be answered is
whether the Petitioner has been able to establish that the Respondents
had vide the Industrial Policy, 2007 and Notification No. 20/2007 made
a promise, which the Petitioner had acted upon putting itself in a
detrimental position which would compel the Respondent No.1 to make
good the promise. If the answer to the first question is in the
affirmative then the second question which also needs to be answered
is whether by issuing the impugned Notification No.20/2008 the
Respondents has done away or curtailed the benefit granted under
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
Notification No.20/2007. To answer the first question it is necessary to
examine the pleadings in the present proceedings.
48.
In paragraph 4 and 5 of W.P. (C) No.41 of 2015 it is pleaded by
the Petitioner that:“4. On the above statutory guarantee for the exemption of the excise duty, the
Petitioner invested Rs.39,26,34,897/- during the period from 2005 to 2008
till the date of notification and total investment till 31/3/2014 is of
Rs.253,89,64,817/-, their capital and started new units and expanded their
existing units in the state of Sikkim.
5.
The Petitioner started their industrial production w.e.f. 20.04.2009. Since
then the Petitioner has been manufacturing P & P Medicaments falling
under Sr.
No.
of the Schedule
to
Notification
56/2003
dated
25.06.2003.”
49.
In paragraph 6 and 7 of the counter-affidavit filed by the
Respondents to W. P. (C) No. 41 of 2015 it is pleaded:“6.
That with reference to paragraph 4 of the writ petition, the Respondents
state that the facts and figures stated therein are within the exclusive
knowledge of the petitioner and the petitioner is put to strict proof thereof.
However, the Respondents state that new unit of the petitioner was not
started within the period 2005 to 2008 and the Respondents vehemently
deny and oppose the said claim of the petitioner. The Respondents further
state that the total investment claim of the Petitioner is within the
exclusive knowledge of the Petitioner and the Petitioner is put to strict
proof thereof.
7.
That with reference to paragraph 5 & 6 of the writ petition, the Respondent
state that the claim of the Petitioner that he started industrial production
w.e.f.
20.04.2009
and
that
the Petitioner
is manufacturing
P
&
P
medicaments falling under Sr. No. 11 of the schedule to Not No. 56/2003-CE
dt. 25.06.2003 is a matter of record which the Petitioner may establish
during the course of the hearing of this instant writ petition. The
Respondents state that reference to para 3 of the said Notification the
petitioner falls within category (a) because the Petitioner started investment
on or after 23rd December 2002 i.e. from 2005. However, the production of P
& P medicament commenced from the year 20.04.2009 which is as per their
paragraph 5 of the writ petition.”
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
50.
In paragraph 4 of the rejoinder filed by the Petitioner it has been
pleaded:“4. That with regard to the statements contained in Para 6 and 7 of the counter
affidavit, it is submitted that the effective step of implementation has been
taken and proper intimation has been filed with appropriate authorities. It is
further submitted that the capital expenditure for establishing new unit has
started in the year 2005, and year wise investment is already given in the
petition. The deponent craves leave of this Hon‘ble Court to rely upon and
produce documents to substantiate the above facts at the time of hearing.”
51.
In paragraph 3(iii) of W.P. (C) No.08 of 2017 it is pleaded by the
Petitioner that:“3(iii) Based on the aforesaid statutory guarantee of 100% excise duty
exemption, the process for establishing a Unit for the manufacturing
of P & P medicaments falling under Serial No. 11 of the Schedule to
the 2003 Notification was commenced as early as in 2005-06. An
area of 1.5750 hectares (i.e. location of the present Sikkim Unit)
was taken on lease. Right from the project stage, nearly 100
employees / workmen were engaged by the Petitioner for the
construction of the Unit. The Petitioner had also been taking the
requisite insurance cover for the workmen required to be engaged
for the project work. Further, in total, the Petitioner had invested an
amount of Rs.20,41,97,593/- between the period from 2005 to 2008
in various Fixed Assets.”
(iv) While things stood thus, vide an Office Memorandum dated
1.04.2007, the Respondent No. 1 notified the North East Industrial
and
Investment
Promotion
Policy
(―Industrial
Policy,
2007‖)
whereby the North East Industrial Policy, 1997 covering States of
Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland
and Tripura stood extended to State of Sikkim. Significantly, the
100% excise duty exemption that was provided under the 2003
Notification (i.e. under the Incentive Scheme, 2003) was also
provided for under the Industrial Policy, 2007. A copy of the
Industrial Policy, 2007 is annexed herewith as Annexure-P7.
(v)
In line with the aforesaid Industrial Policy, 2007, the Respondent
No. 1 issued Notification 20/2007 dated 25.04.2007 whereby goods
specified under the First Schedule to the Central Excise Tariff Act,
1985 other than those mentioned in the annexure to the aforesaid
Notification and cleared in the State of Sikkim were exempted from
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
so much of the duty of excise leviable thereon under the said Act as
is equivalent to the amount of duty paid by the manufacturer of
goods other than the amount of duty paid by utilization of CENVAT
credit. A copy of the Notification No.20/2007 dated 25/4/2007 is
annexed herewith as Annexure-P8.
(vi) In short, the 100% excise duty exemption provided under Industrial
Policy, 2007 read with Notification 20/2007 were the same as that
provided under the 2003 Notification.
(vii) Given the legislative intent behind the continuation of the 100%
excise duty benefits for goods cleared in State of Sikkim (including
those manufactured by the Petitioner), the Petitioner continued to
make its investments in Sikkim for the setting up of Unit. The
Petitioner did everything necessary under law so as to allow it to
engage people of Sikkim in employment at their plant. Consequently
a large number of people from Sikkim are in employment of the
Petitioner working at the Unit for the manufacture of the goods. In
total, the investments made by the Petitioner from 2005 to 2014
can be summarized as follows,
(Rs in Lakhs)
Financial
Year
Net Investments in
fixed assets &
Capital Work in
Progress
Cumulative
Investments in
fixed assets &
Capital Work in
Progress
2005-06
50.31
50.31
2006-07
1799.83
1850.14
2007-08
191.84
2041.98
2008-09
2970.81
5012.79
2009-10
3657.79
8670.58
2010-11
2523.82
11194.40
2011-12
2744.04
13938.44
2012-13
3481.78
17420.22
2013-14
4012.93
21433.15
Total
21433.15
”
52.
In paragraph 6, 7, 8 and 9 of the counter-affidavit filed by the
Respondents to W. P. (C) No. 08 of 2017 it is pleaded:-
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
“6.
That with reference to the statements and allegations made at
paragraphs 3 (i,ii,iii and iv) are matter of records.
7.
That with reference to the statements and allegations made at
paragraphs 3 (v) it is submitted that the Respondent No. 1 (Union of
India) issued Notification No. 20/2007-CE dated 25.04.2007 for
availing area based exemption with certain conditions and the
assessee has to fulfil the conditions stipulated in the notification to
avail the exemption benefit. The Petitioner cannot be accorded Suo
Motto benefit of an exemption notification because it is decided fact
of law that ―it is the foundation for availing the benefit under
notification, it cannot be said that they are mere procedure
requirements with no consequences attached for non-observance.
The consequences are denial of benefit under notification for
availing benefit under exemption notification the conditions are to
be strictly complied with.‖
8.
That with reference to the statements and allegations made at
paragraphs 3 (vi) it is submitted that the Notification No. 20/2007 is
different from the Notification No. 56/2003 in respect of period of
commencement of commercial production.
9.
That with reference to the statements made at paragraphs 3 (vii) it
is submitted that the respondents have no comment.”
53.
In paragraph 8 of the W.P. (C) No.27 of 2017 it is pleaded by the
Petitioner that:“8. Based on the aforesaid statutory guarantee of 100% excise duty
exemption, the process for establishing a Unit for the manufacture
of P & P medicaments, falling under Serial No. 11 of the Schedule to
the 2003 Notification was commenced. An area of 1.57 50 hectares
(i.e. location of the present Sikkim Unit) was taken on lease. Right
from the project stage, nearly 100 direct / indirect workmen were
engaged by the Petitioner for the construction of the Unit. The
Petitioner had also been taking the requisite insurance cover for the
workmen required to be engaged for the project work. Further, in
total, the Petitioner had invested an amount of Rs.20,41,97,593/between the period from 2005 to March 2008 in various Fixed
Assets for establishing said manufacturing unit.”
54.
In paragraph 8 of the counter-affidavit filed by the Respondents
to W. P. (C) No.27 of 2017 it is pleaded:-
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
“8. That with reference to the statements made at paragraph 8 no
comments.”
55.
In paragraph 7 of W.P. (C) No.40 of 2017 it is pleaded by the
Petitioner that:“7. Based on the aforesaid statutory guarantee of 100% excise duty
exemption, the Petitioner, in 2005 and thereafter, the process for
establishing a New Unit (―Unit-1‖) for the manufacture of P & P
medicaments, falling under Serial No. 11 of the Schedule to the
Notification 56/2003 was commenced, including leasing of the land
for establishing the said unit, generating employment in the State,
etc.”
56.
In paragraph 8 of the counter-affidavit filed by the Respondents
to W. P. (C) No.40 of 2017 it is pleaded:“8. That with reference to the statements made at paragraphs 6 to 9 of
the Writ Petition, no comment.”
57.
A conjoint and wholesome reading of the pleadings in the
present proceedings and specifically those quoted above makes it
unequivocally clear that the Petitioner started its investment only in
the year 2005 and thereafter. When the Petitioner thus started its
investment in the year 2005 the incentive scenario in Sikkim was that
under the previous regime Notification No. 56/2003 by which the
Industrial Policy, 2003 was operationalized had been amended vide
impugned Notification No.27/2004 by making it clear that only those
new industrial units which have commenced commercial production on
or after 23.12.2002 but not later than 31.03.2007 would be entitled to
the exemption. It is an admitted fact that the Petitioner started its
commercial production on and from 20.04.2009 for its first unit.
However, the intention of the Respondent No.1 to offer central excise
duty exemption was unequivocal. The Respondent No. 1 had both
knowledge and intention that the said promise would be acted upon. It
is evident that the Petitioner could not avail the benefit of Notification
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
No. 56/2003 as amended by Notification No. 27/2004 as it did not
commence commercial production till 31.03.2007 i.e. the cut of date.
It is also evident that the Respondent No.1 had made a promise and
pursuant thereto the Petitioner had made substantial investments.
Between the periods 09.07.2004 i.e. the date of issuance of impugned
Notification No. 27/2004 till 01.04.2007 the date on which the
Industrial Policy, 2007 was declared the policy continued to be as
provided in Notification No. 56/2003 and as amended by impugned
Notification No. 27/2004 i.e. that of 100% exemptions from excise
duty. Thus the submission of the Petitioner that the investments were
made in establishing its unit due to the clear promise held out by the
Respondent No.1 is surely not out of place. A reading of the
investment chart adverted to by the Petitioner in paragraph 3(vii) of
W.P. (C) No.08 of 2017 to which the Respondent No.1 had no
comment to offer in the counter-affidavit, it is seen that the Petitioner
had made substantial investments between the period of issuance of
impugned Notification No. 20/2007 and the issuance of the impugned
Notification No. 20/2008. The Petitioner asserts that “Given the
legislative intent behind the continuation of the 100% excise duty
benefits for goods cleared in the State of Sikkim (including those
manufactured by the petitioner), the petitioner continued to make
investment in Sikkim for setting up for unit. The Petitioner did
everything necessary under law so as to allow it to engage people of
Sikkim in employment at their plant. Consequently a large number of
people from Sikkim are in employment of the Petitioner working at the
unit for the manufacture of the goods.” The Petitioner further asserts
that the total net investment in fixed assets and capital work in
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
progress from the year 2005 till the year 2014 is 21433.15 lakhs. The
Respondents in its counter affidavit states that they have no comment
to make. Thus the investments made by the Petitioner as detailed in
the investment chart must be accepted. It is quite evident that the
Petitioner had in fact altered its position and made further huge
investments to avail of the promise held out by the Respondent No. 1
to its detriment.
58.
The Appellant in re: Motilal Padampat Sugar Mills Co. Ltd. v. State of
Uttar Pradesh & Ors15 was engaged in the business of manufacture and
sale of sugar. The State Government gave an assurance that new
vanaspati units in the State which went into commercial production by
30.09.1970 would be given concession in sale tax for a period of 3
years. The Appellant set up the vanaspati unit and went into
commercial production on 02.07.1970 and sought exemption. In
August 1970, by which time the Appellant had already gone into
commercial production, the Government rescinded its earlier decision
taken in January 1970.
A Writ Petition filed in the High Court was
rejected and the matter travelled to the Apex Court.
After a detailed
discussion of its authorities the Apex Court would hold:-
“24. … The law may, therefore, now be taken to be settled as a result
of this decision, that where the Government makes a promise knowing or
intending that it would be acted on by the promisee and, in fact, the
promisee, acting in reliance on it, alters his position, the Government would
be held bound by the promise and the promise would be enforceable against
the Government at the instance of the promisee, notwithstanding that there is
no consideration for the promise and the promise is not recorded in the form
of a formal contract as required by Article 299 of the Constitution. It is
elementary that in a republic governed by the rule of law, no one, howsoever
high or low, is above the law. Everyone is subject to the law as fully and
completely as any other and the Government is no exception. It is indeed the
pride of constitutional democracy and the rule of law that the Government
stands on the same footing as a private individual so far as the obligation of
(1979) 2 SCC 409
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
the law is concerned: the former is equally bound as the latter. It is indeed
difficult to see on what principle can a Government, committed to the rule of
law, claim immunity from the doctrine of promissory estoppel. Can the
Government say that it is under no obligation to act in a manner that is fair
and just or that it is not bound by considerations of ―honesty and good faith‖?
Why should the Government not be held to a high ‗standard of rectangular
rectitude while dealing with its citizens‘? There was a time when the doctrine
of executive necessity was regarded as sufficient justification for the
Government to repudiate even its contractual obligations; but, let it be said to
the eternal glory of this Court, this doctrine was emphatically negatived in
Anglo-Afghan Agencies case [Union of India v. Anglo-Afghan Agencies, AIR
1968 SC 718] and the supremacy of the rule of law was established. It was
laid down by this Court that the Government cannot claim to be immune from
the applicability of the rule of promissory estoppel and repudiate a promise
made by it on the ground that such promise may fetter its future executive
action. If the Government does not want its freedom of executive action to be
hampered or restricted, the Government need not make a promise knowing or
intending that it would be acted on by the promisee and the promisee would
alter his position relying upon it. But if the Government makes such a promise
and the promisee acts in reliance upon it and alters his position, there is no
reason why the Government should not be compelled to make good such
promise like any other private individual. The law cannot acquire legitimacy
and gain social acceptance unless it accords with the moral values of the
society and the constant endeavour of the courts and the legislature, must,
therefore, be to close the gap between law and morality and bring about as
near an approximation between the two as possible. The doctrine of
promissory estoppel is a significant judicial contribution in that direction. But
it is necessary to point out that since the doctrine of promissory estoppel is an
equitable doctrine, it must yield when the equity so requires. If it can be
shown by the Government that having regard to the facts as they have
transpired, it would be inequitable to hold the Government to the promise
made by it, the court would not raise an equity in favour of the promisee and
enforce the promise against the Government. The doctrine of promissory
estoppel would be displaced in such a case because, on the facts, equity
would not require that the Government should be held bound by the promise
made by it. When the Government is able to show that in view of the facts as
have transpired since the making of the promise, public interest would be
prejudiced if the Government were required to carry out the promise, the
court would have to balance the public interest in the Government carrying
out a promise made to a citizen which has induced the citizen to act upon it
and alter his position and the public interest likely to suffer if the promise
were required to be carried out by the Government and determine which way
the equity lies. It would not be enough for the Government just to say that
public interest requires that the Government should not be compelled to carry
out the promise or that the public interest would suffer if the Government
were required to honour it. The Government cannot, as Shah, J., pointed out
in Anglo-Afghan Agencies case [Union of India v. Anglo-Afghan Agencies, AIR
1968 SC 718] , claim to be exempt from the liability to carry out the promise
‗on some indefinite and undisclosed ground of necessity or expediency‘, nor
can the Government claim to be the sole Judge of its liability and repudiate it
‗on an ex parte appraisement of the circumstances‘. If the Government wants
to resist the liability, it will have to disclose to the court what are the facts
and circumstances on account of which the Government claims to be exempt
from the liability and it would be for the court to decide whether those facts
and circumstances are such as to render it inequitable to enforce the liability
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
against the Government. Mere claim of change of policy would not be
sufficient to exonerate the Government from the liability: the Government
would have to show what precisely is the changed policy and also its reason
and justification so that the court can judge for itself which way the public
interest lies and what the equity of the case demands. It is only if the court is
satisfied, on proper and adequate material placed by the Government, that
overriding public interest requires that the Government should not be held
bound by the promise but should be free to act unfettered by it, that the court
would refuse to enforce the promise against the Government. The court would
not act on the mere ipse dixit of the Government, for it is the court which has
to decide and not the Government whether the Government should be held
exempt from liability. This is the essence of the rule of law. The burden would
be upon the Government to show that the public interest in the Government
acting otherwise than in accordance with the promise is so overwhelming that
it would be inequitable to hold the Government bound by the promise and the
court would insist on a highly rigorous standard of proof in the discharge of
this burden. But even where there is no such overriding public interest, it may
still be competent to the Government to resile from the promise ‗on giving
reasonable notice, which need not be a formal notice, giving the promisee a
reasonable opportunity of resuming his position‘ provided of course it is
possible for the promisee to restore status quo ante. If, however, the
promisee cannot resume his position, the promise would become final and
irrevocable. Vide Ajayi v. R.T. Briscoe (Nigeria) Ltd. [Ajayi v. R.T. Briscoe
(Nigeria) Ltd., (1964) 1 WLR 1326 (PC)]”
59.
In re: Pournami Oil Mills & Ors. v. State of Kerala & Anr16
under the order dated 11.04.1979 of the Kerala Government, new
small scale units were invited to set up their industries in the State
of Kerala and with a view of boost industrialisation, exemption from
sales tax and purchase tax for a period of 5 years, which was to run
from the date of commencement of production, was extended as a
concession. By a subsequent notification dated 29.09.2980 the
Government withdrew the exemption from sales tax to the limit
specified in the proviso of the said notification. The Apex Court
would hold thus:-
“7. ....................If in response to such an order and in consideration of the
concession made available, promoters of any small scale concern have set up
their industries within the State of Kerala, they would certainly be entitled to
plead the rule of estoppel in their favour when the State of Kerala purports to
act differently. Several decisions of this Court were cited in support of the
stand of the appellants that in similar circumstances the plea of estoppel can
be and has been applied and the leading authority on this point is the case of
(1986) supp. SCC 728
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
M.P. Sugar Mills [Motilal Padampat Sugar Mills Co. Ltd. v. State of U.P.,
(1979) 2 SCC 409 : 1979 SCC (Tax) 144] . On the other hand, reliance has
been placed on behalf of the State on a judgment of this Court in Bakul
Cashew Co. v. STO [(1986) 2 SCC 365 : 1986 SCC (Tax) 385] . In Bakul
Cashew Co. case [(1986) 2 SCC 365 : 1986 SCC (Tax) 385] this Court found
that there was no clear material to show any definite or certain promise had
been made by the Minister to the concerned persons and there was no clear
material also in support of the stand that the parties had altered their position
by acting upon the representations and suffered any prejudice. On facts,
therefore, no case for raising the plea of estoppel was held to have been
made out. This Court proceeded on the footing that the notification granting
exemption retrospectively was not in accordance with Section 10 of the State
Sales Tax Act as it then stood, as there was no power to grant exemption
retrospectively. By an amendment that power has been subsequently
conferred. In these appeals there is no question of retrospective exemption.
We also find that no reference was made by the High Court to the decision in
M.P. Sugar Mills' case [Motilal Padampat Sugar Mills Co. Ltd. v. State of U.P.,
(1979) 2 SCC 409 : 1979 SCC (Tax) 144] . In our view, to the facts of the
present case, the ratio of M.P. Sugar Mills' case [Motilal Padampat Sugar Mills
Co. Ltd. v. State of U.P., (1979) 2 SCC 409: 1979 SCC (Tax) 144] directly
applies and the plea of estoppel is unanswerable.
8. It is not disputed that the first order namely, the one dated April 11, 1979
gave more of tax exemption than the second one. The second notification
withdrew the exemption relating to purchase tax and confined the exemption
from sales tax to the limit specified in the proviso of the notification. All
parties before us who in response to the order of April 11, 1979 set up their
industries prior to October 21, 1980 within the State of Kerala would thus be
entitled to the exemption extended and/or promised under that order. Such
exemption would continue for the full period of five years from the date they
started production. New industries set up after October 21, 1980 obviously
would not be entitled to that benefit as they had notice of the curtailment in
the exemption before they came to set up their industries.‖
60.
In re: Manuelsons Hotels Private Limited v. State of Kerala & Ors. the
State Government by a Government Order, on the recommendation of
the Respondent No.1, declared tourism as an industry enabling those
involved in tourism promotional activities to become eligible for
concessions/incentives as applicable. Exemption from building tax
levied by the Revenue Department was one such concession. In the
said Government Order it was stated that action would be taken to
amend the Kerala Building Tax Act, 1975. Persons eligible for such
concessions were to be classified starred hotels. A Committee was set
up. The Appellant‟s hotel project was approved vide letter dated
25.03.1997 by the Respondent No.1 to be set up in Calicut. Pursuant
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
to the Government Order dated 11.07.1986 and the approval, the
construction of the hotel began and was completed in 1991. On receipt
of a notice for filing returns under the Kerala Building Tax Act, the
Appellant replied that under Government Order dated 11.07.1986 they
were under no obligation to furnish any return as they were exempt
from payment of building tax. The Kerala Building Tax Amendment
Act, 1990 was passed w.e.f. 06.11.1990 adding section 3A giving
power to the Government to make exemption from payment of
building tax for the purpose of promotion of tourism. By a Writ Petition
filed in 1989 the notice issued to the Appellant to file returns was
challenged which resulted in the Appellant being relegated to the
Committee set up. The exemption promised by the Government Order
dated 11.07.1986 was denied to the Appellant on the ground that
section 3A had been omitted w.e.f. 01.03.1993 and the power to grant
exemption having itself being taken away no such exemption could be
granted to the Appellant. Thereafter, the Authority required the
Appellant to submit a statutory return which was also challenged and
ultimately the High Court allowed the Original Petition and directed the
Committee to consider the matter afresh in the light of the judgment
of the Apex Court in re: Motilal Padampat Sugar Mills Co. Ltd. (supra).
The Authorities however once again rejected the application seeking
exemption from property tax which led the filing of another Writ
Petition in the High Court which, however, rejected it holding that no
exemption notification had, in fact, been issued under Section 3A
when it was in existence and therefore no claim for exemption from
payment of building tax would be allowed. The High Court also held
that mere promise to amend the law does not hold out the promise of
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
exemption from payment of building tax and further that since Section
3A itself had been omitted the question of exempting the Appellants
from building tax would not arise. After examining its authorities as
well as various English authorities, the Apex Court would hold:-
“14. It is important to notice that the necessary exemption notification
in Motilal Padampat case [Motilal Padampat Sugar Mills Co. Ltd. v. State of
U.P., (1979) 2 SCC 409 : 1979 SCC (Tax) 144 : (1979) 2 SCR 641] had not
been issued under Section 4 of the U.P. Sales Tax Act, 1948. Yet, this Court
held that sales tax for the period in question could not be recovered. This was
done presumably because promissory estoppel is itself an equitable doctrine.
One of the maxims of equity is that one must regard as done that which ought
to be done. In this view of the matter, it is obvious that the High Court
judgment is incorrect when it holds that as no exemption notification was, in
fact, issued by the Government under Section 3-A, the petitioner would have
to be denied relief. This judgment has been followed repeatedly and has been
applied to give the benefit of sales tax exemption in similar circumstances in
Pournami Oil Mills v. State of Kerala [Pournami Oil Mills v. State of Kerala,
1986 Supp SCC 728 : 1987 SCC (Tax) 134] , Supp SCC at paras 7 and 8.”
Then again
“20. The above statement, based on various earlier English
authorities, correctly encapsulates the law of promissory estoppel with one
difference—under our law, as has been seen hereinabove, promissory
estoppel can be the basis of an independent cause of action in which
detriment does not need to be proved. It is enough that a party has acted
upon the representation made. The importance of the Australian case is only
to reiterate two fundamental concepts relating to the doctrine of promissory
estoppel—one, that the central principle of the doctrine is that the law will not
permit an unconscionable departure by one party from the subject-matter of
an assumption which has been adopted by the other party as the basis of a
course of conduct which would affect the other party if the assumption be not
adhered to. The assumption may be of fact or law, present or future. And two,
that the relief that may be given on the facts of a given case is flexible
enough to remedy injustice wherever it is found. And this would include the
relief of acting on the basis that a future assumption either as to fact or law
will be deemed to have taken place so as to afford relief to the wronged party.
21. In the circumstances, the High Court judgment when it holds that
no notification was, in fact, issued under Section 3-A of the Kerala Building
Tax Act, 1975 (which would be sufficient to deny the appellants relief) is,
therefore, clearly incorrect in law.‖
Then again
“36. In the present case, it is clear that no writ of mandamus is being
issued to the executive to frame a body of rules or regulations which would be
subordinate legislation in the nature of primary legislation (being general rules
of conduct which would apply to those bound by them). On the facts of the
present case, a discretionary power has to be exercised on facts under
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
Section 3-A of the Kerala Building Tax Act, 1975. The non-exercise of such
discretionary power is clearly vitiated on account of the application of the
doctrine of promissory estoppel in terms of this Court's judgments in Motilal
Padampat [Motilal Padampat Sugar Mills Co. Ltd. v. State of U.P., (1979) 2
SCC 409 : 1979 SCC (Tax) 144 : (1979) 2 SCR 641] and Nestle [State of
Punjab v. Nestle India Ltd., (2004) 6 SCC 465] . This is for the reason that
non-exercise of such power is itself an arbitrary act which is vitiated by nonapplication of mind to relevant facts, namely, the fact that a G.O. dated 11-71986 specifically provided for exemption from building tax if hotels were to be
set up in the State of Kerala pursuant to the representation made in the said
G.O. True, no mandamus could issue to the legislature to amend the Kerala
Building Tax Act, 1975, for that would necessarily involve the judiciary in
transgressing into a forbidden field under the constitutional scheme of
separation of powers. However, on facts, we find that Section 3-A was, in
fact, enacted by the Kerala Legislature by suitably amending the Kerala
Building Tax Act, 1975 on 6-11-1990 in order to give effect to the
representation made by the G.O. dated 11-7-1986. We find that the said
provision continued on the statute book and was deleted only with effect from
1-3-1993. This would make it clear that from 6-11-1990 to 1-3-1993, the
power to grant exemption from building tax was statutorily conferred by
Section 3-A on the Government. And we have seen that the Statement of
Objects and Reasons for introducing Section 3-A expressly states that the said
section was introduced in order to fulfil one of the promises contained in the
G.O. dated 11-7-1986. We find that the appellants, having relied on the said
G.O. dated 11-7-1986, had, in fact, constructed a hotel building by 1991. It is
clear, therefore, that the non-issuance of a notification under Section 3-A was
an arbitrary act of the Government which must be remedied by application of
the doctrine of promissory estoppel, as has been held by us hereinabove. The
ministerial act of non-issue of the notification cannot possibly stand in the way
of the appellants getting relief under the said doctrine for it would be
unconscionable on the part of the Government to get away without fulfilling
its promise. It is also an admitted fact that no other consideration of
overwhelming public interest exists in order that the Government be justified
in resiling from its promise. The relief that must, therefore, be moulded on the
facts of the present case is that for the period that Section 3-A was in force,
no building tax is payable by the appellants. However, for the period post-13-1993, no statutory provision for the grant of exemption being available, it is
clear that no relief can be given to the appellants as the doctrine of
promissory estoppel must yield when it is found that it would be contrary to
statute to grant such relief. To the extent indicated above, therefore, we are
of the view that no building tax can be levied or collected from the appellants
in the facts of the present case. Consequently, we allow the appeal to the
extent indicated above and set aside the judgment of the High Court.”
61.
The Industrial Policy, 2003 of the Respondent No.1 had clearly
declared that the State of Sikkim lags behind in industrial development
and need had been felt for structured interventionist strategies to
accelerate industrial development of the State and boost investor
confidence. The new initiatives declared by the Industrial Policy, 2003
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
would provide the required incentives as well as an enabling
environment for industrial development, improve availability of capital
and increase market access to provide a fillip to the private investment
in the State. Fiscal incentives to new industrial units and substantial
expansion of existing units was declared to be 100% income tax and
excise duty exemption for a period of 10 years from the date of
commencement of commercial production. The Industrial Policy, 2003
admitted that Sikkim is one of the least industrially developed States
in India, heavily dependent on the Respondent No.1 for grants and
there was a need to undertake an all round development effort to be
at par with other States of the country. Thus, it was felt necessary to
identify the priorities and emphasise the significance of the twin
objective of speedy industrial development and generation of adequate
employment opportunities. It was stated that keeping these objectives
in mind, the industrial policy attempts to satisfy the aspirations of the
people through economic and industrial development of the State. One
of the main strategies for the implementation of the policy of the
Industrial Policy, 2003 was to announce attractive package and fiscal
objectives. The Respondent No.1 described the current scenario and
future prospects in the Industrial Policy, 2003 in the following words:“2. THE CURRENT SCENARIO AND FUTURE PROSPECTS.
1. 1.80 percent of the population lives in rural Sikkim and agriculture plays a
dominant role in the State economy. With the total cultivable land of around
70.000 hectares, the per capita availability of land is a meagre 0.18 hectares.
The rugged mountainous terrain, fragmentation of land erosion of the hilly
tracts, geographical
seclusion of Sikkim from mainland India, bottlenecks
transportation, dependence on traditional methods of cultivation, etc, have
contributed to the low productivity of agricultural crops and difficulties in
undertaking large scale farming. Consequently, there has been very limited
improvement in the methods of agriculture over the years.
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
2. The main crops produced area rice, wheat, maize, large cardamom and ginger
with potential for the commercialization of large cardamom, ginger, fruits,
tea, medicinal herbs and exportable flowers. There are large areas of fallow
land available, which can be converted into productive farms for cash crops.
3. Sikkim produce 80 percent of India‘s large cardamom, which enjoys a high
value export market in Pakistan, Singapore and the Middle-East. The ginger is
also of a good quality and has export prospects. The large cardamom and
ginger can hence be converted into value added products. Fruits can be
processed for value addition. Exotic flowers can be cultured for export. Honey
and tea are other agro-based products that have high potential.
4. There is a good market for the minor forest produce of the State. The varied
altitude is ideal for the cultivation of a variety of herbs which can be used in
the manufacture of medicines, cosmetics and aromatic products. The climate
is ideal for the development of mulberry trees and hence, the establishment
of a sericulture industry.
5. The absence of profitable marketing network and the lack of appropriate
processing facilities for manufacturing quality finished products has resulted in
most of the produce being sold at uncompetitive prices to other states as raw
materials, and their true potential has not been exploited. Therefore, due
attention needs to be given for the development of agro-based, food
processing and forest based units.
6. There are good prospects for setting up dairy and animals husbandry units on
a commercial basis. The milk production offers opportunities for developing
processed food-products like cheese, butter, etc. The population being
predominantly non-vegetarian, meat-processing and packaging units offer
promise in the State.
7. The State has a good resource base of minerals like zinc, lead, copper,
dolomite, coal, quartzite, graphite, talc etc. Commercial exploitation of some
of these minerals is being carried out by the Sikkim Mining Corporation.
8. The traditional, cottage industries and specially handicrafts enjoy a good
national and international market but more needs to be done on upgrading
quality and design, as well as production and also improvement in the
marketing network.
9. The abundant natural beauty of Sikkim offers a good potential to attract
foreign and domestic tourists, and is conducive to the setting up of tourist
spots, holiday resorts leisure camps of trekking and adventure sports
activities. However, to develop and sustain the tourism industry, adequate
travel and tourism related infrastructure needs to be created, conference
tourism can also be promoted.
10. The state is dependent only on a network of roadways for transportation. At
present, no air or water transport facilities are available. During the monsoon
period transportation is hampered due to landslides etc. Therefore there is an
urgent case for upgrading the road transportation network to and from Sikkim
to other parts of India.
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
11. Accommodation facilities at present only adequate for tourists and must
therefore be enhanced. The overall power situation though comfortable must
be suitably enhanced to induce more power intensive industries to the State.
12. Human resources need to be developed with the ultimate objective of creating
the necessary skills commensurate will the future industry and market
requirements.
13. The current industrial scenario is not very encouraging. As on 31/03/1996
there were 1683 provisionally registered and 313 permanently registered
private sector industrial units, most of which are in the tiny or small sector
promoted by first generation entrepreneurs. There are 14 State Public Sector
Enterprises but no Central Government Public Sector Units in the State.
14. Of the registered industrial units only 225 (two hundred & twenty five) units
are functioning while most of the other units are sick. Some of the State
Public Sector enterprise are also incurring continuous losses and have
accumulated heavy debts over the years.”
62.
It was in this background that the Respondent No.1, satisfied
that it was necessary in the public interest to issue Notification
No.56/2003 exempted, inter alia, P & P medicaments falling under sl.
No. 11 of the schedule to the Notification No. 56/2003 manufactured
by the Petitioner and cleared from the units located in the State of
Sikkim from so much of the duty of excise leviable thereon as is
equivalent to the amount of duty paid by the manufacturer of goods
other than the amount of duty paid by utilisation of CENVAT credit
under the CENVAT Credit Rules, 2002. This incentive continued even
when the Industrial Policy, 2007 was declared by the Respondent No.1
on 01.04.2007 approving a package of fiscal incentives and other
concessions for the North East Region naming it advisedly the „North
East Industrial and Investment Promotion Policy (NEIIPP), 2007‟. The
coverage of the Industrial Policy, 2007 was declared to be the States
of the North East Region of India including Sikkim. In the said
Industrial Policy, 2007 all new units as well as existing units which go
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
in for substantial expansion, unless otherwise specified and which
commences commercial production within the 10 year period from the
date of notification declaring the Industrial Policy, 2007 will be eligible
for incentives for a period of 10 years from the date of commencement
of commercial production. As per the said Industrial Policy, 2007 the
Petitioner who admittedly commenced commercial production on and
from 20.04.2009 for the first unit and 14.04.2014 for the second unit
was well within the 10 year period from the date of notification of the
declaration of the Industrial Policy, 2007 i.e. 01.04.2007. The said
Industrial Policy, 2007 clearly declared that 100% excise duty
exemption would be continued, on finished products made in the North
Eastern Region, as was available under the North Eastern Industrial
Policy (NEIP), 1997 announced on 24.12.1997. It was by this
notification declaring the Industrial Policy, 2007 that the NEIP, 1997
and other concessions in the North Eastern Region seized to operate
w.e.f. 01.04.2007. The natural corollary to the declaration of the
Industrial Policy, 2007 was the issuance of Notification No. 20/2007 on
25.04.2007 which exempted P & P medicaments manufactured by the
Petitioner and cleared from the units located in the State of Sikkim
from so much of the duty of excise leviable thereon as is equivalent to
the amount of duty paid by the manufacturer of goods other than the
amount of duty paid by utilisation of CENVAT credit under the CENVAT
Credit Rules, 2004. The said Notification No. 20/2007 clearly stated
that the said exemption shall apply to new industrial units which
commence commercial production on or after 01.04.2007 but not later
than 01.03.2017. The Petitioner having commenced commercial
production admittedly on 20.04.2009 for the first unit and on
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
14.04.2014 for the second unit was entitled to seek the benefit under
the said Notification No. 20/2007. The exemption contained in the said
Notification No. 20/2007 was to apply to any of the said units for a
period not exceeding 10 years from the date of publication of the said
notification i.e. 25.04.2007 or from the date of commercial production
i.e. 20.04.2009 for the first unit and 14.04.2014 for the second unit
whichever is later.
63.
The declaration of the Industrial Policy, 2003 for the State of
Sikkim and thereafter the Industrial Policy, 2007 for the entire North
East Region including Sikkim makes it clear that the Respondent No.1
was satisfied that it was necessary in the public interest to exempt
inter-alia excise duty on P & P medicaments manufactured by the
Petitioner and cleared from the units located in the State of Sikkim
initially in the year 2003 and thereafter again in the year 2007 keeping
in mind the fact that Sikkim was one of the least industrially developed
States in India. 100% exemption of both income tax as well as excise
duty is a definite attractive fiscal incentive strategy which would lure
investors to set up units in Sikkim without which, considering the
under development of industries and the geographical terrain of the
region, industrialist may not find feasible to invest in. Having thus
declared such attractive incentives and lured the Petitioner to invest in
Sikkim any alteration in the incentive package to the detriment of the
investor would definitely attract the doctrine of promissory estoppel.
The Respondent No. 1 cannot be allowed the unconscionable departure
from the subject matter of the assumptions which has, as seen
hereinabove, been adopted by the Petitioner as the basis of the course
of conduct which would affect the Petitioner adversely.
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
64.
As the Petitioner had failed to commence commercial production
within the period 23.12.2002 to 31.03.2017 as specified by Notification
No. 56/2003 as amended by Notification No.27/2004 it was not
entitled to claim exemption under the aforesaid notification as held
above. Consequently, we shall refrain from examining the challenge to
the impugned Notification Nos. 27/2004, 21/2008 and 36/2008.
65.
Coming now to the next point canvassed by the Learned
Additional Solicitor General that, in fact, the impugned Notification No.
20/2008 does not actually digress from the Industrial Policy, 2007 as
put into operation by Notification No. 20/2007 as in actuality, as
demonstrated by the chart quoted and adverted to above, the
Petitioner would still be entitled to the 100% excise duty exemption.
The
Notification
No.20/2007
was
amended
by
the
impugned
Notification No. 20/2008. Consequently the preamble to the amended
Notification No.20/2007 would read thus:
“In exercise of the powers. conferred by sub-section (1) of the section 5A of
the Central Excise Act, 1944 (1 of 1944), the Central Government, being
satisfied that it is necessary in the public interest so to do, hereby exempts
the goods specified in the First Schedule to the Central Excise Tarrif Act, 1985
(5 of 1986) other than those mentioned in the Annexure and cleared form a
unit located in the State of Assam or Tripura or Meghalaya or Mizoram or
Manipur or Nagaland or Arunachal Pradesh or Sikkim, as the case may be,
from so much of the duty of excise leviable thereon under the said Act as is
equivalent to the duty payable on value addition undertaken in the
manufacture of the said goods by the said unit.”
(Emphasis supplied).
66.
The intention of the Respondent No.1 was made clear. After the
amendment to Notification No.20/2007 by impugned Notification
No.20/2008 the exemption of excise duty equivalent to the amount of
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
duty paid other than the amount of duty paid by utilisation of CENVAT
credit under the CENVAT Credit Rules, 2004 was now to be equivalent
only to the duty payable on value addition undertaken in the
manufacture of the said goods by the said unit.
67.
Under the amended paragraph 2A of Notification No.20/2007 as
amended by impugned Notification No. 20/2008 the duty payable on
value addition shall be equivalent to the amount calculated as a
percentage of the total duty payable on the excisable goods. For the
goods i.e. P & P medicaments falling under chapter 30 of the first
schedule, the rate prescribed in the table to the amended paragraph
2A was 56%. Reading of the amended paragraph 2A leaves no room
for doubt that the total 100% exemption once declared by the
Industrial Policy, 2007 and as put into operation by Notification No.
20/2007 was hugely reduced to only 56% that too only on the value
addition undertaken in the manufacture of the said goods. Simply put
value addition is the amount by which the value of any good is
increased at each stage of its production, exclusive of initial cost.
Whereas in the original Notification No. 20/2007, the exemption on
payment of excise duty was referable to the excise duty payable on
the finished goods in the impugned Notification No. 20/2008 the excise
duty was restricted to the quantum of value addition only. This surely
was something not promised vide the Industrial Policy, 2007 and
Notification No. 20/2007.
68.
The learned Additional Solicitor General relying on the amended
paragraph 3 of the Notification No.20/2007 as amended by impugned
Notification No.20/2008 would argue that the option given to the
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
manufacturer not to avail the rates specified in paragraph 2A and
instant applying to the commissioner for fixation of a special rate
would ensure that in genuine cases manufacturers could avail 100%
duty exemption. A perusal of paragraph 3 makes it clear that the said
fixation of special rate must be representing the actual value addition
in respect of any goods if the manufacturer finds that four fifth of the
ratio of actual value addition in the production or manufacture of the
said goods to the value of the said goods, is more than the rate
specified in the table expressed as a percentage.
The impugned
notification therefore substantially curtails the 100% exemption from
the whole of excise duty other than the amount of duty paid by
utilisation of CENVAT credit under the CENVAT Credit Rules, 2004.
Notification No. 20/2007 provided exemption of full refund of the
actual duty paid less CENVAT credit. The impugned Notification
No.20/2008 however did away with full refund of the actual duty paid
less CENVAT credit and instead the exemption was now to be based on
value addition undertaken by the manufacturer made available product
wise on varied rates of exemption. The proviso to paragraph 3(6) of
the amended Notification No. 20/2007 as amended by impugned
Notification No. 20/2008 which reads ―Provided that the refund shall
not exceed the amount of duty paid on such goods, other than by
utilisation of CENVAT credit.‖ perhaps makes it clear that in no case
can the exemption of duty as envisaged by the impugned Notification
No.20/2008
could
actually
exceed
the
exemption
granted
by
Notification No.20/2007. The impugned Notification No.38/2008 which
further amends the new paragraph 2A as inserted by impugned
Notification No. 20/2008 merely provides now that ―the duty payable
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
on value addition shall be equivalent to the amount calculated as a
percentage of the total duty payable on the said excise goods of the
description specified in column (3) of the Table below (hereinafter
referred to as the said Table) and falling within the chapter of the first
schedule as are given in the corresponding entry in column (2) of the
said Table when manufactured starting from inputs specified in
the corresponding entry in column (5) of the said Table in the
same factory, at the rates specified in the corresponding entry in
column (4) of the said Table.‖ [Emphasis supplied]. The Table provided
in the new paragraph 2A vide impugned Notification No. 20/2008 to
Notification No. 20/2007 has also been replaced with the new Table as
provided in impugned Notification No. 38/2008. This Table however
continues the rate of exemption of duty payable on value addition
undertaken in the manufacture of the said goods by the said unit to
the 56% as was prescribed in the impugned Notification No. 20/2008.
Thus the intent and purport of whittling down the 100% exemption of
excise duty promised, declared and granted vide Notification No.
20/2007 continued vide the impugned Notification No. 38/2008.
69.
The learned Additional Solicitor General would also argue that
the impugned notification stating clearly that the said notification had
been issued in public interest it is for the Court to presume that in fact
the impugned notification was issued in public interest and the onus
would lie on the Petitioner to show otherwise. The impugned
Notification No. 20/2008 was a notification amending the original
Notification No. 20/2007 issued in public interest granting exemption
of payment of excise duty. In such situation it was incumbent upon the
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
Respondent
No.1
to
have
shown
larger
public
interest
for
curtailing/modifying/withdrawing exemption so granted.
70.
In re: Pawan Alloys & Casting (P) Ltd. v. U.P. SEB17.
“10. It is now well settled by a series of decisions of this Court that the
State authorities as well as its limbs like the Board covered by the sweep of
Article 12 of the Constitution of India being treated as ―State‖ within the
meaning of the said article, can be made subject to the equitable doctrine of
promissory estoppel in cases where because of their representation the party
claiming estoppel has changed its position and if such an estoppel does not fly
in the face of any statutory prohibition, absence of power and authority of the
promisor and is otherwise not opposed to public interest, and also when
equity in favour of the promisee does not outweigh equity in favour of the
promisor entitling the latter to legally get out of the promise.
11. In this connection we may usefully refer to a decision of this Court
rendered in the case of State of H.P. v. Ganesh Wood Products [(1995) 6 SCC
363] . B.P. Jeevan Reddy, J. speaking for a Bench of two learned Judges of
this Court made the following pertinent observations in this connection in
paras 54 and 55 of the Report: (SCC pp. 390-91)
―54. The doctrine of promissory estoppel is by now well
recognised in this country. Even so it should be noticed that it is an
evolving doctrine, the contours of which are not yet fully and finally
demarcated. It would be instructive to bear in mind what Viscount
Hailsham said in Woodhouse Ltd. v. Nigerian Produce Ltd. [1972 AC
741 : (1972) 2 All ER 271 : (1972) 2 WLR 1090] —
‗I desire to add that the time may soon come when
the whole sequence of cases based upon promissory estoppel
since the war, beginning with Central London Property Trust
Ltd. v. High Trees House Ltd. [1947 KB 130 : 62 TLR 537 :
1947 LJR 77] may need to be reviewed and reduced to a
coherent body of doctrine by the courts. I do not mean to say
that they are to be regarded with suspicion. But as is common
with an expanding doctrine, they do raise problems of
coherent exposition which have never been systematically
explored.‘
55. Though the above view was expressed as far back as
1972, it is no less valid today. The dissonance in the views expressed
by this Court in some of its decisions on the subject emphasises such
a need. The views expounded in Motilal Padampat Sugar Mills Co. Ltd.
v. State of U.P. [(1979) 2 SCC 409 : 1979 SCC (Tax) 144] was
departed from in certain respects in Jit Ram Shiv Kumar v. State of
Haryana [(1981) 1 SCC 11] which was in turn criticised in Union of
India v. Godfrey Philips India Ltd. [(1985) 4 SCC 369 : 1986 SCC
(1997) 7 SCC 251
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
(Tax) 11] The divergence in approach adopted in Shri Bakul Oil
Industries v. State of Gujarat [(1987) 1 SCC 31 : 1987 SCC (Tax) 74]
and Pournami Oil Mills v. State of Kerala [1986 Supp SCC 728 : 1987
SCC (Tax) 134] is another instance. The fact that the recent decision
in Kasinka Trading v. Union of India [(1995) 1 SCC 274] is being
reconsidered by larger Bench is yet another affirmation of the need
stressed by Lord Hailsham for enunciating ‗a coherent body of
doctrine by the courts‘. An aspect needing a clear exposition — and
which is of immediate relevance herein — is what is the precise
meaning of the words ‗the promisee … alters his position‘, in the
statement of the doctrine. The doctrine has been formulated in the
following words in Motilal Padampat Sugar Mills Co. Ltd. [(1979) 2
SCC 409 : 1979 SCC (Tax) 144] : (SCC p. 442, para 24)
‗The law may, therefore, now be taken to be settled as a
result of this decision, that where the Government makes a
promise knowing or intending that it would be acted on by the
promisee and, in fact, the promisee, acting in reliance on it,
alters his position, the Government would be held bound by the
promise and the promise would be enforceable against the
Government at the instance of the promisee, notwithstanding
that there is no consideration for the promise and the promise
is not recorded in the form of a formal contract as required by
Article 299 of the Constitution‘.‖
We may say at this stage that at the time the aforesaid decision was
rendered, judgment of this Court in the case of Kasinka Trading v. Union of
India [(1995) 1 SCC 274] was pending scrutiny before a larger Bench.
Subsequently the said decision came to be confirmed by the decision of a
Bench of three learned Judges of this Court speaking through A.M. Ahmadi,
C.J. in the case of Shrijee Sales Corpn. v. Union of India [(1997) 3 SCC 398] .
We will refer to these decisions in the latter part of this judgment. Suffice it to
say at this stage that if a statutory authority or an executive authority of the
State functioning on behalf of the State in exercise of its legally permissible
powers has held out any promise to a party, who relying on the same has
changed its position not necessarily to its detriment, and if this promise does
not offend any provision of law or does not fetter any legislative or quasilegislative power inhering in the promisor, then on the principle of promissory
estoppel the promisor can be pinned down to the promise offered by it by way
of representation containing such promise for the benefit of the promisee.”
Then again
“27. Shri Dave, learned Senior Counsel for the Board, next contended
that the Board in exercise of its statutory powers had earlier decided to grant
rebate of 10% on the bills of electricity consumed by new industries. In the
exercise of the same statutory power it was open to the Board to withdraw
the said concession or rebate on the ground of public policy and doctrine of
promissory estoppel cannot be pressed into service for thwarting such an
exercise by the Board. For supporting this contention he vehemently pressed
into service two decisions of this Court in the case of Kasinka Trading v. Union
of India [(1995) 1 SCC 274] and in the case of Shrijee Sales Corpn. v. Union
of India [(1997) 3 SCC 398]. In fact these two decisions were the sheetanchor of the challenge mounted by Shri Dave for the Board against the
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
finding of the High Court on Issue No. 1. We, therefore, now proceed to deal
with these decisions.
28. In the case of Kasinka Trading [(1995) 1 SCC 274] a Bench of two
learned Judges of this Court consisting of M.N. Venkatachaliah, C.J. and Dr.
A.S. Anand, J., had to consider the question whether a notification issued
under Section 25 of the Customs Act, 1962 granting complete exemption
from payment of customs duty to PVC resin imported into India by
manufacturers of certain products requiring the said resin as one of the raw
materials, which was issued in public interest and which had stated that it
would remain in force up to and inclusive of 31-3-1981 could be withdrawn
before the expiry of the said period by fresh notification issued by the
Government in exercise of the very same power under Section 25 of the
Customs Act. This Court speaking through Dr Anand, J., took the view that as
the said notification was issued in public interest it could be withdrawn even
before the time fixed therein for its operation also in public interest and while
issuing such a notification no promise can be said to have been held out or
any representation made to the importers in general on the basis of which
they could insist on the doctrine of promissory estoppel that the customs duty
exemption granted earlier by the first notification could not be reduced by the
second one. The following pertinent observations are found in paras 11 and
12 of the Report: (SCC pp. 283-84)
―11. The doctrine of promissory estoppel or equitable
estoppel is well established in the administrative law of the
country. To put it simply, the doctrine represents a principle
evolved by equity to avoid injustice. The basis of the doctrine is
that where any party has by his word or conduct made to the
other party an unequivocal promise or representation by word
or conduct, which is intended to create legal relations or effect
a legal relationship to arise in the future, knowing as well as
intending that the representation, assurance or the promise
would be acted upon by the other party to whom it has been
made and has in fact been so acted upon by the other party,
the promise, assurance or representation should be binding on
the party making it and that party should not be permitted to
go back upon it, if it would be inequitable to allow him to do so,
having regard to the dealings, which have taken place or are
intended to take place between the parties.
12. It has been settled by this Court that the doctrine of
promissory estoppel is applicable against the Government also
particularly where it is necessary to prevent fraud or manifest
injustice. The doctrine, however, cannot be pressed into aid to
compel the Government or the public authority ‗to carry out a
representation or promise which is contrary to law or which was
outside the authority or power of the officer of the Government
or of the public authority to make‘. There is preponderance of
judicial opinion that to invoke the doctrine of promissory
estoppel clear, sound and positive foundation must be laid in
the petition itself by the party invoking the doctrine and that
bald expressions, without any supporting material, to the effect
that the doctrine is attracted because the party invoking the
doctrine has altered its position relying on the assurance of the
Government would not be sufficient to press into aid the
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
doctrine. In our opinion, the doctrine of promissory estoppel
cannot be invoked in the abstract and the courts are bound to
consider all aspects including the results sought to be achieved
and the public good at large, because while considering the
applicability of the doctrine, the courts have to do equity and
the fundamental principles of equity must for ever be present to
the mind of the court, while considering the applicability of the
doctrine. The doctrine must yield when the equity so demands
if it can be shown having regard to the facts and circumstances
of the case that it would be inequitable to hold the Government
or the public authority to its promise, assurance or
representation.
It may, however, be mentioned that in para 21 of the Report the Court has
observed that the notification which was impugned before it was not designed
or issued to induce the appellants to import PVC resin. Admittedly, the said
notification was not even intended as an incentive for import. The notification
on the plain language of it was conceived and issued by the Central
Government ―being satisfied that it was necessary in the public interest so to
do‖. Strictly speaking, therefore, the notification could not be said to have
extended any ―representation‖ much less a ―promise‖ to a party getting the
benefit of it to enable it to invoke the doctrine of promissory estoppel against
the State. It must, therefore, be held that the aforesaid decision had clearly
proceeded on the basis that by issuing the earlier notification under Section
25 of the Customs Act no promise was held out to any of the importers that
the notification's life will not be curtailed earlier. Nor was the issuance of the
notification based on any claim of incentives to be offered to anyone. It was
issued in exercise of statutory powers vested in the Government which could
be exercised from time to time in public interest. Earlier the public interest
might have required issuance of such a notification granting cent per cent
exemption from customs duty on import of PVC resin. Under changed
circumstances public interest itself required reduction of such an exemption
and as no promise was held out that this could not be done at any time the
Court on the facts of that case justifiably rejected the plea of promissory
estoppel. It is also to be observed that the said notification was issued in
exercise of sovereign taxing power and had created no legal relationship
between the authority issuing the notification on the one hand and the
prospective importers of PVC resin on the other. The said decision is not an
authority for the proposition that even if a claim of exemption from import
duty was resorted to in public interest by way of an incentive for a class of
importers and even though such public interest continued to subsist during
the currency of such an exemption notification and that promisees for whose
benefit such exemption was granted had changed their position relying on the
said exemption notification, it could still be withdrawn before the time
mentioned therein even though public interest did not require the said
exercise to be undertaken and even though there were subsisting equities in
favour of the promisee-importers. As such a situation had not arisen in that
case it was not adjudicated upon.
29. The said decision, therefore, cannot be of any real assistance to
learned Senior Counsel Shri Dave for the respondent-Board on the facts of the
present group of matters. In the present cases, as we have seen earlier a
clear-cut scheme of incentives for new industries was put forward by the
Board presumably at the behest of the U.P. Government so that more and
more industries could be attracted to State of U.P. The Board also in its
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
wisdom adopted the said scheme of incentives while fixing schedule of tariff
rates as that was also in the interest of the Board for the obvious reason that
thereby more and more new industries as consumers of high-power electricity
would be attracted to the region and would be paying higher electricity
rates/charges to the Board.”
Then again
“31. In the light of this settled legal position we, therefore, hold that
even though the appellants have succeeded in convincing us that the earlier
three notifications dated 29-10-1982, 13-7-1984 and 28-1-1986 did contain a
clear promise and representation by the Board to the prospective new
industrialists that once they established their industries in the region within
the territorial limits of the operation of the Board, they would be assured 10%
rebate on the total bills regarding consumption of electricity by their
industries for a period of three years from the initial supply of electric power
to their concerns, the appellants will not be able to enforce the equity by way
of promissory estoppel against the Board if it is shown by the Board that
public interest required it to withdraw this incentive rebate even prior to the
expiry of three years as available to the appellants concerned. It has also to
be held that even if such withdrawal of development rebate prior to three
years is not based on any overriding public interest, if it is shown that by such
premature withdrawal the appellant-promisees would be restored to status
quo ante and would be placed in the same position in which they were prior to
the grant of such rebate by earlier notifications the appellants would not be
entitled to succeed. We, therefore, now proceed to examine these twin
aspects of the controversy.”
71.
In re: State of Punjab v. Nestle India Ltd. & Anr.18 the Chief
Minister of Punjab declared in a State level function of dairy farmers
that the State Government had abolished purchased tax on milk and
milk products in the State which was widely published in newspapers.
The Chief Minister reiterated that declaration in his budget speech also
and the Finance Minister stated that such exemption would assist the
milk producers and milk cooperatives. The circular issued by the Excise
and Taxation Commissioner intimated the field officers that the
Government had decided to abolish purchase tax on milk. The
representatives of the Respondent companies were also informed of
the circular. Finally, the Finance Department formally approved the
proposal to abolish purchase tax on milk and the council of Ministers
(2004) 6 SCC 465
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
gives
his
formal
approval.
Consequently,
the
Respondent
milk
producers did not pay the purchase tax for the specific period and this
point was clearly stated in the returns of that particular year. The tax
authorities did not reject the returns. The Respondents claimed the
benefit was passed on by them to the dairy farmers. The State
Government did not deny these facts. In the end of the year the State
Government in fact published advertisements claiming credit for the
abolition. Subsequently in the Minutes of the Meeting of the Council of
Ministers it was cryptically recorded that the decision to abolish
purchase tax on milk was not accepted. Consequently the ETO issued
notices to the Respondents requiring them to pay the amount of
purchase tax. A number of Writ Petitions were filed before the High
Court challenging the demand.
The High Court held that the
Respondents had acted on the representation made and could not be
asked to pay purchase tax w.e.f. 01.04.1996 but would be liable after
the decision of the Government for the subsequent period i.e. from
04.06.1997. The State Government then filed appeals before the Apex
Court. In the said facts the Apex Court would hold :“47. The appellant has been unable to establish any overriding public
interest which would make it inequitable to enforce the estoppel against the
State Government. The representation was made by the highest authorities
including the Finance Minister in his Budget speech after considering the
financial implications of the grant of the exemption to milk. It was found that
the overall benefit to the State's economy and the public would be greater if
the exemption were allowed. The respondents have passed on the benefit of
that exemption by providing various facilities and concessions for the
upliftment of the milk producers. This has not been denied. It would, in the
circumstances, be inequitable to allow the State Government now to resile
from its decision to exempt milk and demand the purchase tax with
retrospective effect from 1-4-1996 so that the respondents cannot in any
event readjust the expenditure already made. The High Court was also right
when it held that the operation of the estoppel would come to an end with the
1997 decision of the Cabinet.”
72.
In re: Sal Steel Limited (supra) a similar situation had arisen in
the State of Gujarat. In the wake of massive earthquake in the Kutch
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
region of Gujarat the Respondent No.1 notified an exemption scheme
exempting goods produced by new industrial units from paying duty
of excise by issuing the original notification. By the two offending
notifications issued subsequently, the basis of the original notification
of granting refund of the amount of duty of excise or additional duty
of excise leviable on the goods other than the amount of duty paid by
utilisation of CENVAT credit was changed. The impugned notifications
substituted the previous exemption by the words ―to the duty payable
on value addition undertaken in the manufacture of the said goods by
the said unit‖, and further provided that the rate of percentage of the
total duty payable at which the relief would be available. These
notifications impugned therein were challenged before the High Court
of Gujarat at Ahmedabad. There was a conflict of opinion in the
Division Bench. D.A. Mehta J. held in favour of the Petitioner and set
aside the impugned notifications which curtailed/modified/substituted
the basis laid down in the original notification declaring it to be bad in
law and holding that new industrial units, which have been set up and
commenced commercial production within the specified period and by
the specified date under the original notification shall be entitled to
the benefit of exemption in the form of refund of excise duty
payable/paid on the goods manufactured and cleared from such new
units set up in the Kutch district without any restriction by operation
of the two notifications impugned therein, provided all other condition
stands satisfied. S.R. Brahmbhatt J. disagreed with the view
expressed by D. A. Mehta J. the matter was referred to Jayant
Patel J. who after recording detailed reasons agreed with the final
conclusion recorded by D. A. Mehta J.
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
73. In re: Reckitt Benckiser (supra) the High Court of Jammu and
Kashmir would have an occasion to examine a similar issue. In order
to boost Industrial activity in the State, Industrial Policy 1998-2003,
2004 was promulgated which remained in operation till 31st of March
2015. The Respondent No. 1 felt the need for structured intervention
strategies to accelerate industrial development and boost investor
confidence to strengthen and broadened the infrastructure base of
the State and also to minimise unemployment problem. Vide a
Notification dated 14.06.2002 the Respondent no. 1 declared new
incentives to new industrial units as well as existing units engaged in
substantial expansion. The Respondent no. 1 approved conversion of
growth centre into total tax free zone for a period of ten years from
the date of commencement of commercial production entitling 100%
excise duty exemption. Pursuant thereto, Notification no. 56/2002
was issued granting such exemption in exercise of the powers under
Section 5A of the Central Excise Act, 1944. The said notification
exempted goods from so much of the duty of excise or additional
duty of excise, as the case may be, leviable thereon, as is equivalent
to the amount of duty paid by the manufacturer of goods, other than
the amount of duty paid by utilisation of CENVAT credit under the
CENVAT Credit Rules, 2002. The exemption contained in the said
notification was to apply to those units who had commenced their
commercial production on or after 14.06.2002 as well as those
industrial units existing before 14.06.2002, but have undertaken
substantial expansion by way of increase installed capacity by not
less than 25% on or before the above date. It was also provided that
the exemption contained in the said notification shall apply to any of
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
the aforementioned units for a period not exceeding 10 years from
the date of publication of the notification or from the date of
commencement of commercial production, whichever is later. The
said notification was amended vide Notification No. 05/2003 dated
13.02.2003 by adding a proviso which read: ―provided that such
refund shall not exceed the amount of duty paid less the amount of
CENVAT credit availed of, in respect of the duty paid on the inputs
used in or in relation to the manufacture of goods cleared under this
notification.‖ Vide Notification impugned therein No. 19/2008 dated
27.03.2008 and 34/2008 dated 10.06.2008 further amendments
were carried out whereby excise duty refund had been restricted to a
maximum limit as mention in the tables appended to the said
notification in respect of the different goods. The said notifications
change the entire scenario by reducing 100% exemption provided by
the earlier notifications to a limited percentage in respect of different
goods manufactured by the units. Further, the said notifications also
restricted the exemption from duty to value addition undertaken in
the manufacture of said goods by the units. The said notifications
impugned therein also gave liberty to an industrial unit to apply to
the Commissioner for determination of actual value addition if the
manufacturer does not agree to the rate of excise duty exemption
which had been made available under the said notifications. The said
notifications amending the original notifications were put to challenge
before the High Court of Jammu and Kashmir at Jammu. The High
Court held that the concept of value addition is relatable to goods
which are actually manufactured in the units from the raw material
after excluding the cost of the said raw material. The actual activity
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
carried out in the manufactured of goods and the cost incurred would
be the value addition. After having promised a 100% refund of excise
duty it was not permissible for the Respondent no. 1 to deviate from
the promise held out by the earlier notification as it cannot be said
that the impugned notifications continued to extend the same
promise as was intended in terms of the earlier notification. It was
also held that the concept of special rate displaces the very
foundation of the rate fixed in terms of the original notification. It was
further held that there was no supervening public interest in
withdrawing the exemption by way of the notifications impugned.
Consequently, the Writ Petitions were allowed and the notifications
impugned therein quashed.
74.
In re: Unicorn Industries (supra) this Court would examine the
legality of Notification No.23/2008 dated 27.03.2008 and Notification
No.37/2008 dated 10.06.2008 withdrawing the exemption granted in
the payment of duty for utilisation towards the CENVAT credit/cash
conferred upon the Petitioner therein by Notification No.71/2003
dated 09.09.2003 issued by the Respondent No.1 exercising the
powers under Section 5A of the Central Excise Act, 1944. Notification
No.71/2003 provided for exempting the goods from so much of the
duty of excise or additional duty of excise as was leviable thereon as
is equivalent to the amount of duty paid by the manufacturer of the
said goods, other than the amount of duty paid by utilisation of
CENVAT credit. Both the Industrial Policy, 2003 as well as Industrial
Policy, 2007 fell for consideration before this Court. It was not in
dispute that based on the statutory guarantee for exemption of excise
duty,
the
Petitioner
therein
invested
and
started
new
units.
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
Notification
No.
23/2008
dated
27.03.2008
and
Notification
No.37/2008 dated 10.06.2008 were challenged before this Court.
Notification No.23/2008 amended the earlier Notification No.71/2003
dated 09.09.2003 by amendments identical to the amendments made
in
the
impugned
Notification
No.20/2008.
The
preamble
to
Notification No. 71/2003 was amended substituting for the words ―to
the amount of duty paid by the manufacturer of the said goods other
than the amount of duty paid by utilisation of CENVAT credit under
the CENVAT Credit Rules, 2002‖, the words ―to the duty payable on
value addition undertaken in the manufacture of the said goods by
the
said
unit‖.
Identically,
as
in
the
impugned
Notification
No.20/2008, Notification No.23/2008 also provided a table in which
for goods falling under chapter 33 a rate of 56% was prescribed.
Similarly Notification No.37/2008 is identical to the impugned
Notification No.38/2008. After examining the matter in detail this
Court would hold that once it is established that the exemption had
been granted in public interest the same cannot at any stretch be
withdrawn unless there is a larger public interest. This Court would
further hold that once power under Section 5A of the Central Excise
Act,
had
larger/superior
been
exercised
and
exemption
granted,
public
interest
has
to
shown
be
a
for
curtailing/modifying/withdrawing an exemption already granted and
in such eventuality, the onus shall be on the Revenue. This Court
would further rely upon the full bench decision of the Gujarat High
Court in Sal Steel Ltd. (supra) holding that withdrawal of exemption
without any basis, whatsoever, is arbitrary, unreasonable, illogical
and irrational and contrary to the doctrine of promissory estoppel.
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
This Court would also hold that once the Respondent No.1 had taken
a policy decision and exercised power under Section 5A of the Central
Excise Act, 1944 in public interest, the same cannot be restricted by
way of the Notification No.23/2008 dated 27.03.2008 and Notification
No.37/2008 dated 10.06.2008 impugned therein unless a greater
public interest required so. Thus holding, this Court quashed the
notifications impugned therein without prejudice to the rights of the
Revenue to deny duty exemptions in appropriate cases, based on
material facts and giving cogent reasons after following due process
of law.
75.
We are in agreement with the aforestated views expressed by
the High Court of Gujarat in re: Sal Steel Ltd. (supra), the High Court
of Jammu and Kashmir in re: Reckit Benckiser (supra) and this Court in
re: Unicorn Industries (supra) which follows the principles of law laid
down by the Apex Court in re: M/s. Motilal Padampat Sugar Mills Co.
Ltd. (supra) and in re: Pawan Alloys & Casting (P) Ltd. (supra).
76.
In re: Modipon Ltd. (supra) the Delhi High Court would hold
that the Courts have consistently taken the view that the public
interest is inherent in issuance of the withdrawal of the notifications.
The public interest is the dominant factor in issuance and withdrawal
of the notifications what is given in public interest can also be taken
away in public interest. Every action of the Government is presumed
to be in public interest unless contrary is proved. The Petitioner have
failed to demonstrate that the notification dated 21.10.1982 was not
issued in public interest. Holding thus, the High Court dismissed the
Writ Petition preferred. While holding so the Delhi High Court would
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
rely upon Kasinka Trading & Anr. v. Union of India19. The distinction
drawn by the Apex Court in re: Pawan Alloys & Casting (P) Ltd.
(supra) would be squarely applicable to the present case. The said
decision, therefore, cannot be of any real assistance to the learned
Additional Solicitor General on the facts of the present Writ Petitions.
In the present cases, as we have seen earlier, a definite scheme of
incentives for new industries was put forward vide Industrial Policy,
2007 which held out a promise by the Respondent No.1 for 100%
excise duty exemption so that more and more industries could be
attracted to State of Sikkim. The Respondent No.1 translated the said
promise declared vide Industrial Policy, 2007 into Notification No.
20/2007
for the obvious reason that thereby more and more new
industries would be attracted to the North East Region including
Sikkim.
77. In re: Kothari Industrial Corporation Limited (supra) relied
upon by the learned Additional Solicitor General, the Apex Court
would hold that a recipient of a concession has no legally enforceable
right against the
Government to
grant or continue
to grant
concession except to enjoy benefits of concession during the period of
its grant.
78.
In the present case the Petitioner seeks to enjoy the benefit
promised by the Respondent No.1 for the period of 10 years as
declared by the Respondent No.1.
(1995) 1 SCC 274
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
79.
In re: R.C. Tobacco (P) Ltd. (supra) relied upon by the learned
Additional Solicitor General, the Apex Court would hold that the
competence of Parliament and the State Legislature to repeal, amend
or supersede an exemption notification is unquestionable. The
limitation on this power is that that the legislation must not conflict
with other provisions of the Constitution. A law cannot be held to be
unreasonable
merely
because
it
operates
retrospectively.
The
unreasonability must lie in some other additional factors. The
retrospective operation of a fiscal statute would have to be found to
be unduly oppressive and confiscatory before it can be held to be so
unreasonable as to violate Constitutional norms. The Apex Court
would find that the particular context of the section impugned therein
was the Industrial Policy formulated by the Central and the State
Government of Assam for development of that State. It was held that
the obvious intention behind the grant of the package of incentives
including an exemption from payment of excise duties was to
stimulate further industrial growth in the area with enduring benefits
not only to the local populace by way of employment opportunities
but also to the economic welfare of the State. It was found that none
of the industrial units manufacturing cigarettes were prepared to
contribute to that object and their investment in the manufacture of
cigarette was co-extensive with the period of the exemption. In the
light of the aforesaid facts it was held by the Apex Court that
therefore, the Government could contend that the words should have
been used in the exemption so as to provide for sufficient safeguards
to ensure that the benefit of exemption was granted only to those
industries which would in turn permanently invest in the State and by
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
the retrospective enactment that defective expression of the object of
the policy, was rectified.
80.
The facts of the present set of Writ Petitions are entirely
different than the facts in re: R.C. Tobacco (P) Ltd. (supra). The
Petitioner does not question the competence of Parliament and the
State Legislature to repeal, amend or supersede an exemption
notification nor is it a case of challenge to a law operating
retrospectively. It is nobody‟s case that the Petitioner was not willing
to contribute to the object of industrial growth and their investment
in the manufacture of P & P medicaments was co-extensive with the
period of the exemption.
81.
In re: DG of Foreign Trade v. Kanak Exports (supra) a
challenge to a notification issued by the Respondent No.1 making
some notes inserted to EXIM Policy, 2002-2007 on the ground that
under the guise of the said notes, some benefits which had already
accrued to the exporters under the EXIM policy i.e. their vested
rights, had been taken away was repelled by the Apex Court holding
that the said notification was only clarificatory in nature and valid and
did not amount to amendment. It also held that the incentive scheme
under the EXIM Policy is in the nature of concession or incentive
which is a privilege of the Respondent No.1 and it is for the
Government to take the decision to grant such privilege or not and
further where there is withdrawal of such incentive and it is also
shown that the same was done in public interest, the Court would not
tinker with these policy decision. In the facts of the said case it was
held that if the status-holders had achieved 25% incremental growth
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
in exports, they acquired the vested right to receive the benefit under
the scheme, which could not be taken away. It was held that the so
called targets achieved were only on paper through fraudulent
means, and, therefore, it cannot be said that any vested right
accrued in favour of the exporters. There was pernicious and blatant
misuse of the provisions of the incentive scheme in question. The
Supreme Court, or for that matter the High Court in exercise of its
writ jurisdiction, cannot come to the aid of such Petitioner exporters
who, without making actual exports, play with the provisions of the
scheme and try to take undue advantage thereof. In the said case the
Apex Court would examine whether the withdrawal notifications were
in public interest. It would find that the main objective of the
incentive scheme was to achieve the share of 1% of global trade and
accelerated growth in exports by India. It would find that immediately
after the introduction of the scheme, there was unprecedented sharp
rise in the export in gem and jewellery articles and that misuse of the
scheme was stated to have come to the notice of the DRI and other
intelligence official also and therefore the notifications were issued to
curb misuse. On such finding of facts it was held by the Apex Court
that the purport behind notification were bonafide which was actuated
with the conditions of public interest in mind.
82. The facts and circumstances in the present case is distinctly
different from the facts and circumstances in re: Kothari Industrial
Corpn. Ltd. (supra). In the present case no material whatsoever has
been placed by the Respondent No.1 to show that the withdrawal was
in public interest save stating that the notification itself states that it
is in public interest leave alone showing a superior public interest to
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
resile from the promise held out clearly vide Industrial Policy, 2007
and 100% exemption granted pursuant thereto vide Notification No.
20/2007.
83. Coming now to the point raised by Mr. Vikram Nankani, learned
Senior Advocate that the Petitioner having inadvertently sought
exemption under Notification No. 56/2003 whereas the Petitioner was
in fact eligible for exemption under the Industrial Policy, 2007 and the
Notification
No.20/2007
the
benefit
which
the
Petitioner
was
otherwise eligible to avail of could not be prohibited from claiming the
same.
84.
In re: Unichem Laboratories (supra) the Apex Court would
hold:“13. For the aforementioned reasons, we are of the view that denial of benefit
of the notification to the appellant was unfair. There can be no doubt that the
authorities functioning under the Act must, as are in duty bound, protect the
interest of the Revenue by levying and collecting the duty in accordance with
law - no less and also no more. It is no part of their duty to deprive an
assessee of the benefit available to him in law with a view to augment the
quantum of duty for the benefit of the Revenue. They must act reasonable
and fairly.”
85. In re: Share Medical Care (supra), the Appellant society imported
certain medical equipments for the use in its charitable hospital.
According to the Appellant, under notification in question, exemption
were granted to hospital equipments imported by the specified
category
of
hospitals
(charitable)
subject
to
certification
by
Directorate General of Health Services (DGHS). The table in the
notification classified hospitals in four categories. According to the
Appellant, it fell under Para No. 3 of the table of the said
notification. The Appellant, however, along with several other
hospitals, had applied for the benefit of exemption notification not
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
under Para 3 but para 2 of the table. The benefit of exemption was
granted. Since the Appellant society was also entitled to exemption
under para 3 of the table an application was made to DGHS,
highlighting the fact that the Appellant is non-profit organisation and
had been permitted to import medical equipments by DGHS by
certification. It has been registered as an institution to receive
donation in foreign exchange and since the areas of operations of
the main hospital at Ghanapur and the Rural Health Hospital are in
rural areas, it would be entitled to invoke para 3 of the table of the
notification of exemption. The Deputy Director General (Medical),
DGHS by an order dated 25.01.2000 rejected the application of
Appellant observing therein that initially the request was made by
the Appellant for exemption under para 2 of the said notification and
accordingly, the institution was granted such exemption. It was,
therefore, not open to apply for exemption under para 3 of the table
of the exemption notification and the application was liable to be
rejected. Being aggrieved, the Appellant Society filed a Writ Petition
in the High Court which was dismissed and the matter travelled to
the Apex Court. The Apex Court would hold:-
“12. In CCE v. Indian Petro Chemicals [(1997) 11 SCC 318] this Court held
that if two exemption notifications are applicable in a given case, the assessee
may claim benefit of the more beneficial one. Similarly, in H.C.L. Limited v.
Collector of Customs [(2001) 9 SCC 83 : (2001) 130 ELT 405] this Court
relying upon Indian Petro Chemicals [(1997) 11 SCC 318] held that where
there are two exemption notifications that cover the case in question, the
assessee is entitled to the benefit of that exemption notification which may
give him greater or larger relief. In Unichem Laboratories Ltd. v. CCE [(2002)
7 SCC 145 : JT (2002) 6 SC 547] the appellant was a manufacturer of bulk
drugs. Exemption was granted to him under one item. He, thereafter, filed a
revised classification list categorising its bulk drugs under the other head
claiming more benefit. The claim was rejected on the ground that the
appellant had not claimed the benefit of exemption at the time of filing the
classification list and subsequently it could not be done. The appellant
approached this Court.
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
13. Allowing the appeal and setting aside the order, this Court held that if no
time is fixed for the purpose of getting benefit under the exemption
notification, it could be claimed at any time. If the notification applies, the
benefit thereunder must be extended to the appellant. The Court held that the
authorities as well as the Tribunal were not right in holding that the appellant
ought to have claimed the benefit of the notification at the time of filing of
classification lists and not at a subsequent stage. The Court then stated: (SCC
p. 150, para 12)
―There can be no doubt that the authorities functioning under the Act
must, as are duty-bound, protect the interest of the Revenue by
levying and collecting the duty in accordance with law—no less and
also no more. It is no part of their duty to deprive an assessee of the
benefit available to him in law with a view to augment the quantum
of duty for the benefit of the Revenue. They must act reasonably and
fairly.‖
(Emphasis supplied)
14. In Kerala State Coop. Marketing Federation Ltd. v. CIT [(1998) 5 SCC
48: JT (1998) 4 SC 145], interpreting Section 80-P(2)(a) of the Income Tax
Act, 1961, this Court said: (SCC p. 52, para 7)
―7. We may notice that the provision is introduced with a view to
encouraging and promoting growth of cooperative sector in the
economic life of the country and in pursuance of the declared policy
of the Government. The correct way of reading the different heads of
exemption enumerated in the section would be to treat each as a
separate and distinct head of exemption. Whenever a question arises
as to whether any particular category of an income of a cooperative
society is exempt from tax what has to be seen is whether income fell
within any of the several heads of exemption. If it fell within any one
head of exemption, it would be free from tax notwithstanding that the
conditions of another head of exemption are not satisfied and such
income is not free from tax under that head of exemption. The
expression ‗marketing‘ is an expression of wide import. It involves
exchange functions such as buying and selling, physical functions
such as storage, transportation, processing and other commercial
activities such as standardisation, financing, marketing intelligence,
etc. Such activities can be carried on by an apex society rather than a
primary society.‖
(Emphasis supplied)
15. From the above decisions, it is clear that even if an applicant does
not claim benefit under a particular notification at the initial stage, he is not
debarred, prohibited or estopped from claiming such benefit at a later stage.”
86.
In view of the above, it is held that the Petitioner which was
entitled to exemption benefit under Notification no. 20/2007 but
sought benefit under Industrial Policy, 2003 and Notification No.
56/2003 would be entitled for the benefit under the Industrial Policy,
2007 as put into operation vide impugned Notification No. 20/2007.
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
87.
We find that the Respondent No.1, right from the year 2003,
had declared a clear policy of 100% excise duty exemption to those
new industrial units who would set up industry in Sikkim as well as
to those industries who went in for substantial expansion. This policy
was
put
into
operation
vide
Notification
No.56/2003.
The
Respondent No.1 had vide impugned Notification No. 24/2004
limited the period within which new industrial units were required to
commence
commercial
production.
The
Petitioner
started
the
process of investment in the year 2005 only and could not start
commercial production until 20.04.2009 by which time, by the
operation of a subsequent impugned Notification No.27/2004, the
Petitioner did not qualify to take the benefit of the said Industrial
Policy, 2003. The Petitioner therefore, is not entitled to the benefit
of Notification No. 56/2003. The industrial policy however, did not
change. In 2007 the Respondent No.1 declared the Industrial Policy,
2007 by which identical 100% excise duty exemption was once
again promised. This Industrial Policy, 2007 was put into operation
vide
Notification
No.20/2007.
The
Petitioner‟s
subsequent
investments were obviously intended to reap the benefit of the said
Notification
No.20/2007.
The
Petitioner
having
commenced
commercial production on and from 20.04.2009 for the first unit and
from 14.04.2014 for the second unit were well within the period
notified therein. The policy of the Respondent No.1 was clear and
cogent. It was intended to draw investors to Sikkim which was
industrially backward. Having acted on the said promise made by
the Respondent No.1, the Petitioner made huge investments and
altered its position to its detriment. Having issued the said
W.P. (C) No.41 of 2015
W.P. (C) No.08 of 2017
W.P. (C) No.27 of 2017
&
W.P. (C) No.40 of 2017
(Sun Pharma Laboratories Limited v. The Union of India & Ors.)
Notification No.20/2007 in public interest it was incumbent upon the
Respondent No.1 to place before this Court all materials available to
establish a superior public interest which the Respondent No.1 has
failed to do. The facts and circumstances of the present writ
petitions, therefore, squarely falls within the parameters of the
doctrine of promissory estoppel and that it would be unconscionable
on the part of the Respondent No.1 to shy away from it without
fulfilling its promise. The relief that must, therefore be granted on
the facts of the present case is that for the period declared vide
Notification No.20/2007 the Petitioner would be entitled to the
excise duty exemption as promised therein. Consequently impugned
Notification Nos.20/2008 and 38/2008 are liable to be quashed to
the extent they curtail and whittle down the 100% excise duty
exemption benefit as promised vide Notification No.20/2007 and is
hereby quashed. All impugned orders/ demand notices/show cause
notices which are against the aforestated declarations of law are
also quashed.
88.
Writ Petition (C) No. 41/2015, Writ Petition (C) No. 08/2017,
Writ Petition (C) No. 27/2017 and Writ Petition (C) No. 40/2017 are
disposed accordingly in the aforesaid terms. Rule made absolute to
the aforesaid extent with no order as to costs.
Avi/tp Approved for reporting: yes.
Internet: yes.
Judge
Chief Justice
21-11-2017
21-11-2017
This page is for informational and research purposes only and does not constitute legal advice.
Consult a qualified advocate for advice specific to your situation.
Is your name in this judgment and should it be masked, or is something on this page wrong?
Request a review